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Abstract 
 
Bovine babesiosis is a tick–borne disease with significant morbidity and mortality, 
and the economic losses associated to this disease can be considerable. Control 
measures of bovine babesiosis include the eradication or reduction of ticks, good 
diagnosis, use of vaccination and correct treatment. The aim of this work was to 
contribute to a better diagnosis of the infection aiming at the improvement of some 
of the control measures, as well as to identify and characterize protease genes for 
the development of a diagnostic method and studied as potential drug targets. 
For this study, collaborative work was carried out in Mozambique, from where 
blood samples from naturally infected cattle were collected in five farms located in 
the Maputo province, south of the country. A new molecular detection PCR method 
was then developed and tested using genomic DNA and random field samples 
collected from one farm. Primers were designed based in the babesial aspartic 
protease putative babesipsin gene identified in the genomes of Babesia bigemina 
and B. bovis. The new seminested hot-start PCR method was developed using the 
combination of 30 bp long primers and a hot start polymerase that theoretically 
allows the use of annealing temperatures above the melting temperatures of the 
primers and prevents the formation of unspecific amplifications and therefore 
increases the specificity. 
The new seminested hot-start PCR method was assayed using 117 field samples in 
parallel with the widely used nested PCR method. The babesipsin seminested hot-
start PCR was in this study more sensitive than the nested PCR. With the 
seminested hot-start PCR, 90% of the samples were positive for B. bigemina and 
82% were positive for B. bovis. The results suggested that bovine babesiosis is 
common and endemic in Mozambique and that the disease was in an endemically 
stable situation. 
The status of bovine babesiosis in Mozambique was then further studied, by 
testing random field samples from four more farms using the seminested hot-start 
PCR. All the samples from the five farms were also analysed using the reverse line 
blot (RLB) assay, and the results were compared with the data obtained by the 
seminested hot-start PCR. The detection of Babesia spp. differed considerably 
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between methods and locations. Using the seminested hot-start PCR, detection of 
B. bigemina between farms varied from 30% to 89% with an overall detection of 
61%, and detection of B. bovis ranged between 27% and 83% with an overall 
frequency of 53%. Using the RLB assay B. bigemina was not detected and detection 
of B. bovis ranged between 0% and 17% with a total frequency of 5.1%. Analysis of 
new sequences of the 18S rRNA gene revealed that the current B. bigemina RLB 
probe is unspecific for the detection of all the identified isolates from Mozambique. 
The seminested hot-start PCR was therefore more sensitive than the RLB assay. 
Nevertheless, ten different species of the four genera Anaplasma, Babesia, Ehrlichia 
and Theileria were detected by the RLB assay, and this illustrates that multiple 
infections are widespread in Mozambique. 
The results of this study show that bovine babesiosis is common in Maputo 
province, but there are some locations with low prevalence of infections and 
therefore the results suggest that this disease is not in an endemically stable 
situation in Maputo province. Further epidemiological studies are now needed to 
corroborate these findings. 
Proteases have been shown to have essential roles in parasitic protozoa and are 
under study as promising drug targets. Some cysteine proteases of protozoan 
parasites are now recognized drug targets and specific inhibitors are in validation 
for chemotherapy of leishmaniasis, malaria, and trypanosomiasis. In this study our 
focus on the identification and characterization of proteases as drug targets was 
therefore in this class of proteases. 
Cysteine protease putative genes were identified by sequence similarity search in 
the ongoing B. bigemina genome sequencing project database and were compared 
with the annotated genes from the complete bovine piroplasms genomes of B. 
bovis, Theileria annulata, and T. parva. Multiple genome alignments and sequence 
analysis were used to evaluate the molecular evolution events that occurred in the 
C1 family of cysteine proteases in these piroplasms of veterinary importance. 
There are five distinct groups of cysteine protease genes of C1 family in B. 
bigemina (5 genes), four groups in B. bovis (4 genes) and six groups in Theileria 
spp. (13 genes). Molecular evolution in Theileria occurred through the duplication 
of genes and sequence diversity. These considerable differences observed in the 
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cysteine protease family between Babesia and Theileria genera, may partially 
explain why Babesia cannot infect lymphocytes and Theileria infect first 
lymphocytes in the vertebrate host. 
One of the identified cysteine proteases in the B. bigemina genome, babesipain-1, 
was expressed as a fusion protein with gluthatione S-transferase (GST) and the 
soluble protein was purified by affinity chromatography. The recombinant 
babesipain-1 showed activity against typical peptide substrates of cysteine 
proteases, and was inhibited by a general inhibitor of its class, but the low yield of 
the soluble purification prevented additional characterization. 
Babesipain-1 was then purified from the insoluble fraction, and the denatured 
protein was refolded and activated to produce an active mature enzyme. Analysis 
of the activity of babesipain-1 revealed typical properties of a papain-family 
cysteine protease, including hydrolysis of typical papain-family peptide substrate, 
an acidic pH optimum (5.5-6.0), requirement for a reducing environment for 
maximum activity, and inhibition by standard cysteine protease inhibitors as E-64, 
leupeptin, ALLN and cystatin. The results suggest that babesipain-1 has a role in 
cytosol environment, since babesipain-1 retained high activity against peptide 
substrates at pH 7.5 (83% of maximum), an uncommon feature of cysteine 
proteases of parasitic protozoa. 
Thus the results of this study demonstrate that bovine babesiosis is widespread in 
Maputo province in Mozambique, although the disease is not in an endemically 
stable situation. The results also suggest that cysteine proteases of Babesia spp. are 
promising drug targets for the development of an effective treatment of bovine 
babesiosis. In face of these results a plan for future work is associated. Some 
aspects and results from this work can be adjusted to other countries, including 
Portugal. 
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Resumo 
 
A babesiose bovina é uma doença transmitida por carraças, que causa elevada 
morbidade e mortalidade, e provoca consideráveis perdas económicas devido aos 
esforços para controlar esta doença. As medidas de controlo da babesiose bovina 
incluem a erradicação ou redução de carraças, correcto diagnóstico, assim como 
tratamento e vacinação apropriados. Este trabalho tem como objectivo contribuir 
para um melhor diagnóstico da infecção e a consequente melhoria de algumas das 
medidas de controlo, bem como identificar e caracterizar genes de proteases 
utilizados para o desenvolvimento de um método de diagnóstico e estudados como 
potenciais alvos para fármacos. 
Para este estudo, foi realizado um trabalho de colaboração em Moçambique, onde 
foram colhidas amostras de sangue de bovinos naturalmente infectados, em cinco 
explorações situadas na província de Maputo, no sul do país. Um novo método de 
detecção molecular por PCR foi desenvolvido e testado utilizando DNA genómico e 
amostras de campo aleatórias colhidas numa das explorações. Os iniciadores de 
PCR foram desenhados com base no gene putativo da protease aspártica 
babesipsina-1 identificado nos genomas de Babesia bigemina e de B. bovis. O novo 
seminested hot-start PCR foi desenvolvido utilizando a combinação de iniciadores 
longos de 30 pb de comprimento e uma hot-start polimerase, que permitem 
teoricamente a utilização de temperaturas de emparelhamento acima da 
temperatura de melting, impedindo assim a formação de amplificações não 
específicas, o que aumenta a especificidade do método. 
O novo seminested hot-start PCR foi avaliado utilizando 117 amostras de campo, e 
em paralelo com um método amplamente utilizado, o nested PCR. O seminested 
hot-start PCR neste estudo foi mais sensível que o nested PCR. Com o seminested 
hot-start PCR, 90% das amostras foram positivas para B. bigemina, e 82% foram 
positivas para B. bovis. Os resultados sugeriram que a babesiose bovina é comum e 
endémica em Moçambique, e que a doença se encontra numa situação de 
estabilidade endémica. 
O estudo do estado da babesiose bovina em Moçambique, foi então aprofundado, 
através da análise de amostras de campo aleatórias de mais quatro explorações 
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utilizando o seminested hot-start PCR. Todas as amostras das cinco explorações 
foram também analisadas utilizando o RLB, e os resultados deste método foram 
comparados com os dados obtidos pelo seminested hot-start PCR. A detecção de 
Babesia spp. diferiu significativamente entre os métodos utilizados e os locais de 
recolha. Com o seminested hot-start PCR, a detecção de B. bigemina nas várias 
explorações, variou entre 30% e 89%, com uma detecção total de 61%, e a 
detecção de B. bovis variou entre 27% e 83% com uma frequência global de 53%. 
Utilizando o RLB, não foi detectado B. bigemina e a detecção de B. bovis variou 
entre 0% e 17% com uma frequência total de 5,1%. A análise de novas sequências 
do gene 18S rRNA, revelou que a actual sonda do RLB para B. bigemina não é 
adequada para a detecção de todos os isolados desta espécie identificados em 
Moçambique. O seminested hot-start PCR foi portanto mais sensível que o RLB. No 
entanto, dez espécies diferentes dos quatro Géneros Anaplasma, Babesia, Ehrlichia 
e Theileria foram detectadas pelo ensaio RLB, e isso demonstra que as infecções 
múltiplas são comuns em Moçambique. 
Os resultados deste estudo mostram que a babesiose bovina é comum na província 
de Maputo, e também que existem alguns locais com baixa prevalência de 
infecções, e portanto, os resultados sugerem que esta doença não está numa 
situação de estabilidade endémica na província de Maputo. São agora necessários 
novos estudos epidemiológicos para confirmar estes resultados. 
Tem sido demonstrado que as proteases têm papéis essenciais em parasitas 
protozoários e estão sob estudo como promissores alvos de fármacos. Algumas 
proteases cisteínicas de parasitas protozoários, são já reconhecidos alvos de 
fármacos, e encontram-se em validação inibidores específicos para a quimioterapia 
da leishmaniose, da malária e da tripanossomíase. Neste estudo, o nosso principal 
interesse na identificação e caracterização de proteases como alvos de fármacos foi 
portanto nesta classe de proteases. 
Foram identificados no banco de dados do projecto em curso de sequenciação do 
genoma de B. bigemina, os genes putativos de proteases cisteínicas em pesquisas 
por similaridade de sequência, que posteriormente foram comparados com os 
genes anotados nos genomas completos das espécies de piroplasmas bovinos B. 
bovis, Theileria annulata e T. parva. Para avaliar os eventos da evolução molecular 
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que ocorreram na família C1 de proteases cisteínicas, foram feitos alinhamentos 
múltiplos entre os genomas e análises das sequências obtidas destes piroplasmas 
de importância veterinária. Existem assim, cinco grupos distintos de genes de 
proteases cisteínicas da família C1 em B. bigemina (5 genes), quatro grupos em B. 
bovis (4 genes) e seis grupos em Theileria spp. (13 genes). No Género Theileria a 
evolução molecular ocorreu através da duplicação de genes e da diversificação da 
sequência das proteínas codificadas por estes genes. Estas importantes diferenças 
observadas entre os Géneros Babesia e Theileria na família das proteases 
cisteínicas, podem parcialmente explicar os diferentes mecanismos de infecção 
destas espécies, em que parasitas Babesia não invadem linfócitos e parasitas 
Theileria invadem primeiro os linfócitos no hospedeiro vertebrado. 
A babesipaína-1, uma das proteases cisteínicas identificadas no genoma de B. 
bigemina, foi expressa como uma proteína de fusão com a glutationa S-transferase 
(GST) e a respectiva fracção solúvel foi purificada por cromatografia de afinidade. 
A babesipaína-1 recombinante apresentou actividade contra certos péptidos que 
são substratos típicos de proteases cisteínicas, e foi inibida por um inibidor geral 
da sua classe, mas o baixo rendimento da purificação da fracção solúvel impediu a 
sua caracterização adicional. 
A babesipaína-1 foi então purificada a partir da fracção insolúvel, e a proteína 
desnaturada foi re-enrolada e activada para produzir uma enzima activa. A análise 
da actividade da babesipaína-1 revelou propriedades típicas de uma protease 
cisteínica da família da papaína, incluindo a hidrólise de alguns péptidos que são 
substratos típicos da família da papaína, um pH ácido óptimo (5.5-6.0), o requisito 
de um ambiente redutor para ter actividade máxima, e a inibição por inibidores de 
proteases cisteínicas como o E-64, a leupeptina, o ALLN e a cistatina. Os resultados 
sugerem que a babesipaína-1 tem um papel no citosol, já que a babesipaína-1 
manteve elevada actividade contra substratos a pH 7,5 (83% do máximo), uma 
característica incomum das proteases cisteínicas de parasitas protozoários. 
Assim, os resultados deste estudo demonstram que a babesiose bovina é uma 
infecção comum na província de Maputo em Moçambique, embora a doença não 
esteja numa situação de estabilidade endémica. Os resultados também sugerem 
que as proteases cisteínicas de Babesia spp. são alvos promissores para fármacos e 
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consequentemente para o desenvolvimento de um tratamento eficaz para a 
babesiose bovina. Na sequência destes resultados foi associado um plano de 
trabalho futuro. Alguns pormenores e resultados deste trabalho podem ser 
transferidos para outros países, inclusivamente Portugal. 
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1.1. Introduction 
Babesiosis caused by intraerythrocytic parasites of the Apicomplexan genus 
Babesia, is a common infection of vertebrate animals worldwide (Uilenberg, 2006). 
In 1893, Smith and Kilbourne discovered that Babesia bigemina, a causative agent 
of bovine babesiosis, was transmitted by the tick Boophilus annulatus. This 
revelation was a breakthrough in the history of parasitology, as it was the first 
proof that an arthropod was the vector of any disease agent (Uilenberg, 2006). 
Ticks from several genera are now known to be vectors and reservoirs of 
numerous Babesia spp. transmissible to reptiles, birds and mammals (Uilenberg, 
2006). The major economic impact of babesiosis is on the cattle industry and the 
two most important species in cattle, B. bigemina and B. bovis threaten the health 
and safety of about 300 million cattle in tropical and subtropical regions of the 
world (Wright, 1990). The pathogenicity varies both between and within species 
but in many cases has a high rate of mortality in susceptible untreated animals 
(Bock et al., 2004). Many factors contribute to the emergence and re-emergence of 
babesiosis: parasite drug resistance, tick resistance to acaricides, genetic evolution, 
and the so-called global change (economic, social and environmental factors) 
(L’Hostis and Seegers, 2002). Climate change and increased climatic variability are 
particularly likely to affect vector borne diseases at the global scale in the near 
future. Control measures of bovine babesiosis include the eradication or reduction 
of ticks, better diagnosis, vaccination and treatment of clinical cases. The ongoing 
genome sequencing projects of Babesia spp., and more importantly, the vast 
knowledge acquired with the study of the closely related malaria pathogen may 
boost the study of Babesia diversity and drug resistance and the development of 
specific fast acting drugs, recombinant vaccines, and of more specific and sensitive 
diagnostic methods currently required for the control of babesiosis. This tick borne 
disease is also gaining increasing interest as an emerging zoonosis in humans, as 
the incidence of babesiosis has been rising steadily both in the U.S.A. and Europe 
(Homer et al., 2000; Hildebrandt et al., 2008). Human babesiosis may have 
previously been overlooked in many parts of the world due to its rarity or a lack of 
medical awareness and microbiological detection methods (Hildebrandt et al., 
2008). On the other hand, the number of patients with risk factors is currently 
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increasing (e.g. immunocompromised individuals and organ transplant recipients) 
and asymptomatic but chronically infected blood donors may be a source of 
transfusion-transmitted babesiosis (Hildebrandt et al., 2008). New and old Babesia 
pathogens of veterinary and medical importance continue to emerge around the 
world and the substantial health impact of babesiosis on livestock and man is 
continuing. 
 
1.2. The Apicomplexa 
The eukaryotic phylum Apicomplexa comprises more than 5000 species of 
endoparasitic protozoa, including the Plasmodium parasites responsible for 
malaria, a major disease of poverty (Cavalier-Smith, 1993; Roos, 2005). 
Apicomplexan parasites infect virtually all animals (Levine, 1985), and while some 
parasite life cycles are relatively simple, involving only a single host, others require 
sexual recombination in a vector species for transmission. Sexual recombination is 
relevant in the production of diverse parasites within a species and this subject 
area is important in understanding drug resistance or immune mechanisms of 
defense.  Some parasites are specialists, restricted to particular species and tissues, 
whereas others are generalists. For example, Plasmodium falciparum, which causes 
the most lethal form of malaria, infects only Hominids, and is transmitted only by 
anopheline mosquitoes. In contrast, Toxoplasma gondii can infect almost any tissue 
of warm-blooded animals. In the complex life cycle stages of Apicomplexan 
parasites, extracellular forms in the host include an apical complex that gives the 
phylum its name, including secretory organelles associated with host cell 
attachment, invasion, and establishment of an intracellular parasitophorous 
vacuole (Sibley, 2004). Different stages of development are also relevant for the 
study of drug targets and their selection. 
 
1.3. The Genus Babesia 
It was at the end of the 19th century that the Romanian biologist Victor Babeş 
discovered micro-organisms in erythrocytes of cattle in Rumania and associated 
them with bovine hemoglobinuria or red water fever (Babes, 1888). Currently it is 
know that members of the genus Babesia are one of the most ubiquitous and 
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widespread blood parasites in the world, second only to the trypanosomes (Homer 
et al., 2000). The genus Babesia belongs to the phylum Apicomplexa, class 
Sporozoasida, order Eucoccidiorida, suborder Piroplasmorina and family 
Babesiidae (Levine, 1971, 1985; Allsopp et al., 1994). The Babesia species sensu 
stricto, or true Babesia, are characterized by transovarial transmission in the 
vector tick and the limitation of infecting only erythrocytes in the host (Uilenberg, 
2006). Babesia organisms are protozoan parasites that are all transmitted by ticks 
to their specific vertebrate host. Completion of a life cycle and therefore the 
maintenance of Babesia are completely dependent on both the tick and the 
vertebrate host (Mehlhorn and Shein, 1984) and therefore, the distribution of all 
the different Babesia species is governed by the geographical distribution of the 
tick vectors that transmit them. The Babesia spp. known to infect cattle, and their 
vectors, are listed in Table 1.1. 
Babesia organisms can be visualized in a Giemsa stained infected blood smear. 
They are pyriform (pear shaped) or seen as round or amoeboid forms (Levine, 
1985). Depending on the Babesia species, a host erythrocyte may be parasitized by 
single, paired, or multiple organisms. The size of the organisms varies depending 
on the species and are therefore classified as either small (1.0-2.5 μm; B. bovis, B. 
gibsoni, B. ovis and B. divergens) or large Babesia (2.5-5.0 μm; B. bigemina, B. caballi 
and B. canis), accordingly to the size of the trophozoites (Levine, 1985). Electron 
microscopy of extracellular forms reveals the presence of an apical complex with 
micronemes, rhoptries, apicoplast and other organelles (Kawai et al., 1986; Kawai 
et al., 1999) characteristic of the phylum Apicomplexa. Babesia extracellular 
infective forms, the sporozoites, move by gliding or body flexion, and lack flagella 
or pseudopodia, characteristic of some Apicomplexans (Levine, 1985). 
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Table 1.1. Known Babesia species of cattle, their ixodid tick vector genus and 
geographical distribution. 
Species  Domestic 
host(s) 
Vector genus Distribution 
B. beliceri a Cattle Hyalomma Russia 
B. bigemina  Cattle, buffalo Boophilus, 
Rhipicephalus 
Africa, America, Asia, 
Australia, Europe 
B. bovis  Cattle, buffalo Boophilus, 
Rhipicephalus 
Africa, America, Asia, 
Australia, Europe 
B. divergens  Cattle, reindeer Ixodes Europe 
B. jakimovi a Cattle, reindeer Ixodes? Siberia 
B. major  Cattle Haemaphysalis Europe 
B. occultans Cattle Hyalomma Africa, Asia 
B. ovata  Cattle Haemaphysalis Asia 
a These species are not recognized by all scientists and some may not be valid. 
Adapted from Uilenberg (2006). 
 
1.3.1. Life Cycle 
The complex life cycle of Babesia spp. takes place in two hosts and sexual and 
asexual reproduction proceeds through at least three stages: 
 
(i) gamogony – sexual development with formation and fusion of gametes 
inside the tick gut, 
(ii) sporogony - asexual reproduction in tick salivary glands, 
(iii) merogony - asexual reproduction in the vertebrate host. 
 
Babesia spp. are not characterized by a life cycle that is specific for the genus 
(Mackenstedt et al., 1995). Therefore, we describe here the life cycle of B. bigemina 
(Fig. 1.1), which is similar to the life cycle of B. bovis. 
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Figure 1.1. The life cycle of Babesia bigemina in cattle and the ixodid tick vector 
Rhipicephalus (Boophilus) microplus. Adapted from Bock et al. (2004). 
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1.3.1.1. Events in the vertebrate host 
Once in the vertebrate, the transmitted bovine Babesia spp. sporozoites do not 
parasitise any vertebrate host cell other than erythrocytes (Mackenstedt et al., 
1995). Each sporozoite penetrates the cell membrane of an erythrocyte with the 
aid of a specialised apical complex, forming a parasitophorous vacuole (Sibley, 
2004). The vacuole membrane gradually disintegrates, and the parasite is left with 
the defining piroplasm feature of a single membrane, in contrast to Plasmodium 
species, which invade by a similar mechanism but retain the host membrane in 
addition to its own. Once inside the erythrocyte, it transforms into a trophozoite 
from which two merozoites develop by a process of merogony (Levine, 1985). The 
merozoites lyse the cell and go on to infect additional erythrocytes. Rapid 
reproduction destroys the host cell and leads to hemoglobinuria in the host. Some 
trophozoites develop into a diploid ovoid type of merozoite, called a gamont 
precursor. These gamont precursors do not develop further until they are taken up 
by the tick in the blood meal (Mackenstedt et al., 1995). 
 
1.3.1.2. Events in the tick 
Environment changes in the passage from host blood to the midgut of the tick 
vector stimulate the development of two populations of gamonts called ray bodies 
(Gough et al., 1998). The ray bodies undergo further multiplication within the 
consumed erythrocyte and form large aggregations of multinucleated ray bodies. 
After the consumed erythrocyte is digested, and once gametogenesis is complete, 
single-nucleated and haploid gametes (Mackenstedt et al., 1995) emerge from the 
aggregates and then fuse together in pairs to form a zygote (Gough et al., 1998; 
Mosqueda et al., 2004). The zygote selectively infects the digestive cell of the tick 
gut where they probably multiply and then the basophilic cells where further 
multiplication occurs. At some stage in development in the gut the zygote 
undergoes one-step meiosis to form a haploid zygote (Mackenstedt et al., 1995). In 
the gut cells, schizogony occurs with the formation of polyploid kinetes, and these 
motile club-shaped kinetes then escape into the haemolymph and infect a variety 
of cell types and tissues, including the oocytes where successive cycles of 
secondary schizogony take place (Mackenstedt et al., 1995). Consequently, 
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transovarial transmission occurs with further development taking place in the 
larval stage. This is an important life cycle adaptation as the Boophilus vectors are 
one-host ticks. Kinetes enter the salivary glands and are transformed into 
multinucleated stages (sporogony) and these then break up to form sporozoites 
(Mackenstedt et al., 1995). In all species, sporozoite development usually begins 
when the infected tick attaches to the vertebrate host. In B. bigemina, infective 
sporozoites take about 9 days to appear and therefore transmission only occur in 
the nymphal and adult stages of the tick (Hoyte, 1961; Potgieter and Els, 1977). In 
the case of B. bovis, the formation of infective sporozoites usually occurs within 2 
to 3 days of larval tick attachment (Riek, 1966), and transmission occurs only in 
this stage as infective sporozoites do not persist beyond the larval stage (Mahoney 
and Mirre, 1979). 
 
1.3.2. Epidemiology 
Different breeds of cattle are known to differ in susceptibility to infection and 
manifestation of clinical signs of babesiosis. Bos taurus breeds are more 
susceptible to both B. bigemina and B. bovis than Bos indicus cattle (Bock et al., 
1997). Age resistance was also demonstrated in calves from non immune mothers 
and this is related to passively acquired resistance from colostrum and innate 
immunity. Calves exposed to babesiosis during the first 6 to 9 months rarely show 
clinical symptoms and develop a solid long-lasting immunity (de Waal and 
Combrink, 2006), and if the infection recurs repeatedly the immunity is 
permanent. Under conditions of endemic instability, some animals will not be 
challenged for some periods after birth and may therefore develop severe, life 
threatening disease if they are exposed later in life (Bock et al., 2004). If at least 
75% of calves are exposed to B. bovis infection by 6 to 9 months of age the disease 
incidence would be very low and a state of natural endemic stability would exist 
(Mahoney, 1974). One infected tick is sufficient to transmit B. bovis, but tick 
infection rates can be low and the rate of transmission to cattle depending on the 
breed is therefore usually slow. The use of tick control with acaricides unbalances 
the natural conditions, and numbers of infected ticks may fall below those required 
to maintain endemic stability. In endemic areas the animals clinically affected are 
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mostly susceptible cattle introduced for breeding purposes, for slaughter, or in 
transit. Severe clinical cases which occur in these cattle are caused by exposure to 
stresses such as parturition and starvation (Bock et al., 2004). Animals that are 
aged, splenectomized or immunocompromised are more susceptible to babesiosis 
than young and healthy animals (Levine, 1985).  
 
1.3.3. Diagnosis and identification of parasites 
Diagnosis of clinical cases of babesiosis is most frequently made by examination of 
blood smears stained with Giemsa or acridine orange (Bӧse et al., 1995; Trees, 
1974). Blood films are prepared from capillary blood, as blood of the general 
circulation may contain up to 20 times fewer B. bovis parasites due to the 
sequestration of infected erythrocytes in the capillaries of the brain and other 
organs (Bӧse et al., 1995). In B. bigemina infections, parasitized cells are evenly 
distributed throughout the blood circulation. Thick blood films are 10 times more 
sensitive and are therefore very useful for the detection of low level B. bovis 
infections (Bӧse et al. 1995). These films differ from thin ones in that the blood is 
not spread over a large area and is not fixed before staining, thus allowing lyses of 
the red blood cells and concentration of the parasites (Bӧse et al. 1995). These 
techniques are inexpensive and reasonably portable. However, the accuracy of 
diagnosis relies on the training and skill of the microscopist. Low parasitaemias 
and the presence of different and morphological similar parasites (e.g. other 
Babesia spp. and also Theileria spp.) may adversely affect the proper classification 
of infections. Diagnosis of babesial infections can be further confirmed by serologic 
evaluation and polymerase chain reaction (PCR) based assays. These tests also 
have improved sensitivity to diagnose chronic or asymptomatic infections, for the 
purposes of research, epidemiological studies, export certification or where 
vaccine breakdowns are suspected. 
Different serodiagnostic tests have been described. The indirect 
immunofluorescence antibody test (IFAT) is the most widely used, while the 
enzyme-linked immunosorbent assay (ELISA) is the test system which holds the 
greatest promise for the future (Bӧse et al. 1995). The advantage that this test has 
over IFAT is that interpretation of results is less subjective and it is easily 
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automated for large numbers of samples, although it requires more antigen and 
very defined assay procedures. Thus far, improvements to the ELISA have been 
limited as the quality of crude antigen preparations made from infected blood is 
generally poor. Potentially, most of the problems associated with crude antigens 
can be overcome by the production of recombinant antigens. Some ELISAs based 
on highly defined recombinant antigens have been described and show promise 
(Goff et al., 2006; Goff et al., 2008). 
In cases that are difficult to diagnose by smear or serology, or when the detection 
of carrier animals with very low parasitaemias is required, the direct detection of 
parasites by PCR based assays is used. With the evolution of more sensitive PCR 
based techniques, several methods have been described including nested PCR 
(Figueroa et al., 1993), reverse line blot (RLB) hybridization (Gubbels et al., 1999), 
LAMP (Iseki et al., 2007) and real time PCR (Buling et al., 2007) for detection and 
differentiation of bovine babesiosis infections. Currently, none of these methods is 
used globally since some of them have not been validated to worldwide use, some 
require complicated post-PCR detection methods to further enhance the sensitivity 
or differentiation, others require special equipment, and also some may be prone 
to amplicon contamination issues. 
 
1.3.4. Treatment and vaccination 
Chemotherapy is generally effective against bovine babesiosis, with essentially the 
same drugs used for B. bigemina and B. bovis. Successful treatment depends on 
early diagnosis and the prompt administration of effective drugs. There is less 
likelihood of success if treatment is delayed until the animal has been weakened by 
fever and anaemia. Current treatments provide protection from clinical diseases 
but usually allow a sufficient level of infection (low level parasitaemias) for 
immunity to develop which is interesting in areas where babesiosis is endemic. 
Only a few babesiacides are now available commercially and diminazene aceturate 
and imidocarb dipropionate are the most widely used: 
 
1) Diminazene – used intramuscularly at a dose of 3.5 mg/kg for treatment (de 
Vos, 1979). 
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2) Imidocarb - used subcutaneously at a dose of 1.2 mg/kg for treatment; is 
also the only chemoprophylactic, at a dose of 3 mg/kg, which will prevent 
clinical infection from B. bovis for 4 weeks and B. bigemina for at least 2 
months (Taylor and McHardy, 1979). 
 
At the high dose of 3 mg/kg, imidocarb may also completely eliminate B. bovis and 
B. bigemina leaving the animals susceptible to reinfection and for this reason 
reduced drug levels are sometimes indicated (Vial and Gorenflot, 2006, Bock et al., 
2004), especially in endemic areas where the development of protective immunity 
is desirable. But, the use of reduced drug levels increases the risk of development 
of resistance against the drug when used extensively (Rodriguez and Trees, 1996). 
When a treatment is carried out on infected animals, and at a later stage parasites 
are detected again in the blood stream, several hypotheses can be made, as: 
 
a) parasites under treatment were resistant to the administered drugs and 
therefore we are in presence of recrudescent parasite resistance; 
b) a new infection has taken place, at a time where the drugs were not any 
longer in the blood stream and had no effect on the new parasites; 
c) there has been no proper metabolization of the drug and therefore 
parasites were not totally affected by the treatment. 
 
In any case, these are examples related to curative treatment and not prophylaxis. 
Imidocarb has a 28-day withholding period for meat consumption and restrictions 
for lactating cattle (the Chemical Safety Information from Intergovernmental 
Organizations, http://www.inchem.org/). Imidocarb at either dose can interfere 
with the development of immunity following live vaccination (de Vos et al., 1986). 
Treatment with long-acting oxytetracycline following vaccination significantly 
reduces parasitaemia and red blood cell destruction without inhibiting the 
development of immunity (Pipano et al. 1987). Oxytetracyclines are not usually 
able to control virulent field infections. Supportive treatment for chemotherapy is 
sometimes desirable, particularly in valuable animals. Blood transfusions may be 
life-saving in very anaemic animals. Anti-inflammatory drugs, such as 
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phenylbutazone, help relieve the inflammatory processes that occur, particularly 
with B. bovis infections (Vial and Gorenflot, 2006). 
In addition to chemotherapy, life attenuated vaccines for cattle are used with over 
95% efficacy from a single vaccination (Bock et al., 2004). Attenuated Babesia spp. 
strains used in vaccines are produced by different methods according to the 
species. Avirulent B. bovis parasites are produced by multiple passages of selected 
isolates in splenectomised calves, and avirulent B. bigemina are produced by 
splenectomising latently infected calves and using the ensuing relapse parasites to 
repeat the procedure in other animals (Bock et al., 2004). In vitro methods have 
also been used to grow attenuated organisms for preparation of live vaccines 
(Shkap and Pipano, 2001). While attenuated live vaccines lead to significant 
decreases in mortality, they do not prevent infection or full protection against 
milder symptoms of the disease (de Waal and Combrink, 2006). Live vaccines have 
been used routinely or experimentally in several countries (de Waal and 
Combrink, 2006; Bock et al., 2004; Shkap and Pipano, 2001). The observed 
decreasing efficiency of live vaccines in some regions, the complicated production 
methods, reduced shelf life and transportation issues, the major risks involved by 
using blood-derived live vaccines like transmission of contaminating pathogens 
and the reported heterogeneity between and within natural isolates urges the 
search for efficient recombinant vaccines (Bock et al., 2004). However the lack of 
understanding of immune mechanisms to primary and secondary infection and the 
fact that many protozoa have developed elaborate mechanisms such as antigen 
variation for evading host immunity remain obstacles to developing effective 
vaccines using recombinant technology (Jenkins, 2001). 
 
1.4. Proteases as drug targets 
Proteases catalyse the cleavage of amide linkages in macromolecular proteins and 
oligomeric peptides. Proteases have been identified in all biological systems from 
viruses to vertebrates. Once thought as only nonspecific digestive enzymes, 
proteases are now also known to be involved in substrate cleavages that result in 
changes of protein function. Proteases are involved in a wide range of biological 
processes such as DNA replication, cell signalling, immunity and apoptosis. From 
General introduction 
14 
 
genome sequencing data it is know that more than 550 proteases are defined in 
the human genome accounting for 2% of the expressed genes and similar 
percentages are present with little variance in all organisms (Puente et al., 2003; 
Wu et al., 2003). In addition, about 77 mutated human proteases have been 
identified to date which often contribute to hereditary diseases and, therefore, 
represent target opportunities (Quesada et al., 2009). Therefore, proteases are 
recognized as one of the largest potential drug target enzyme families. In addition, 
there are many more proteases found in viruses, bacteria, and parasites, which are 
also potential drug targets, due to their lower homology to their mammalian 
orthologs, and offer target opportunities to identify selective inhibitors that have 
minimal cross-reactivity with mammalian proteases (McKerrow et al., 2008). The 
inhibition of HIV-1 protease and human angiotensin-converting enzyme (ACE) 
involved in hypertension and congestive heart failure, demonstrated the potential 
of protease inhibitors in the treatment of infections and other diseases (Lüthi, 
2002). Currently, several other proteases are in advance stages of study. Clinical 
development of protease inhibitors for diabetes, cancer, thrombosis, and 
osteoporosis is advancing. Phase III clinical trials are ongoing for the inhibitor 
Telaprevir (VX-950) of Hepatitis C virus NS3 protease and the inhibitor Rupintrivir 
(AG7088) of common cold human Rhinovirus 3C protease (Lüthi, 2002). The 
cysteine protease of the protozoan parasite Trypanosoma cruzi, cruzipain, is a 
validated target of effective inhibitors, and the drug candidate K777, is in late 
preclinical trials for Chagas disease (Doyle et al., 2007). Some HIV antiretroviral 
drugs have also been found to have anti-malarial and anti-giardiasis properties 
(Dunn et al., 2007; Martins et al., 2006). The widespread use of protease inhibitors 
as effective therapy for hypertension and AIDS, confirmed that proteases are 
valuable drug targets and current research will likely increase the number of 
available chemotherapeutic strategies based on the inhibition of proteases. 
Drugs for treatment of infections must be very inexpensive for widespread use in 
resource poor regions. Many protease inhibitors can be made cheaply. The 
chemistry of protease inhibitors is so diverse that inexpensive synthetic schemes 
using simple starting materials can be developed or selected. The cost of HIV 
protease inhibitors is dependent on market considerations. HIV protease 
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inhibitors are being distributed to economically poor regions of the world at 
increasingly lower cost (WHO, Towards universal access, Scaling up priority 
HIV/AIDS interventions in the health sector, progress report 2008). Also, many 
viral or parasite infections will require only short courses of treatment, leading to 
much cheaper therapeutic regiments compared to the chronic treatment required 
for hypertension, diabetes or chronic viral infections (McKerrow et al., 2008). 
 
1.4.1. Protease classification 
Proteases (or peptidases) are divided into seven classes on the basis of the 
catalytic mechanism used during the hydrolytic process: (1) serine proteases, (2) 
threonine proteases, (3) cysteine proteases, (4) glutamic proteases, (5) 
metalloproteases, (6) aspartic proteases and (7) unknown. In the first three 
classes, an amino acid residue (serine, threonine or cysteine respectively) acts as 
the catalytic nucleophile that binds to the target peptide bond, whereas in the case 
of the glutamic, metallo and aspartic proteases a water molecule performs that 
role. Each of the main classes is subdivided into clans, which are further divided 
into families according to sequence homology (Rawlings et al., 2008). 
 
 
1.4.2. Proteases of Babesia and other Apicomplexans 
Since members of the Apicomplexa are obligate intracellular parasites, their 
survival depends on their ability to invade host cells, avoid degradation by host cell 
machinery and propagate intracellularly. Thus, in these organisms, proteases carry 
out tasks common to many eukaryotes as well as functions highly specific to the 
parasite life cycles. The Apicomplexa are named for the unique set of secretory 
organelles that are closely related with these functions. Data from diverse 
pathogens like Plasmodium, Toxoplasma, Eimeria and Cryptosporidium place the 
proteolytic processing by cysteine and serine proteases of parasite surface 
proteins, required for attachment and penetration, in the centre of parasite 
rupture and subsequent invasion of host cells (Binder and Kim, 2004; Koussis et 
al., 2009; Wickham et al., 2003; Smith et al., 2005; Fetterer et al., 2007). In 
Plasmodium, aspartic, cysteine and metallo- proteases are also important in the 
critical metabolic process of the digestion of haemoglobin in the acidic food 
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vacuole (Francis et al., 1997). Proteolytic enzymes play key roles in the life cycle of 
Apicomplexa protozoan parasites or the pathogenesis of diseases they produce, 
and therefore, proteases have been validated as drug targets in a number of 
parasitic infections including malaria, toxoplasmosis, and cryptosporidiosis 
(McKerrow et al., 2008). 
An initial analysis of the P. falciparum genome revealed over 90 genes with 
homology to well characterized protease families (Wu et al., 2003) and Toxoplasma 
gondii is likely to encode as many protease genes (www.toxodb.org). The 
distribution by protease classes of the putative genes of P. falciparum (11% 
aspartic, 36% cysteine, 22% metallo, 17% serine, and 14% threonine) resembles 
those in other model organisms, and is noteworthy that cysteine proteases 
predominate as in many other parasitic protozoa (North et al., 1990). Therefore, it 
is not surprising that the early studies on proteases from Piroplasms were made in 
the identification of cysteine protease genes from Theileria spp. (Baylis et al., 1992; 
He et al., 2005; Holman et al., 2002; Nene et al., 1990; Sako et al., 1999). However, 
the identification of such enzymes or other proteases has not been explored in 
detail in Babesia species. Recently a serine protease from B. divergens, BdSUB-1, 
was identified and localized in the apical complex dense granules (spherical 
bodies), and anti-BdSUB-1 antibodies had an inhibitory effect on the invasion 
process (Montero et al., 2006). Serine proteases were also shown to be important 
in the invasion process and growth of B. divergens by inhibition of in vitro cultures 
with the serine class inhibitors TPCK and TLCK (Montero et al., 2007). It was also 
showed recently, that the lipophilic cysteine protease class inhibitors E-64d and 
ALLN reduced in vitro the invasion of erythrocytes as well as the growth of B. bovis 
(Okubo et al., 2007). Therefore, the possibility of developing selective inhibitors of 
key proteases of Babesia parasites into novel chemotherapeutic strategies can be 
explored with probable success. 
 
1.5. Outline of the study 
In this study, the identification of protease genes from bovine Babesia spp. was 
prosecuted in order to develop a new diagnosis method (Chapter 2 and 3) and to 
characterize potential drug targets for the future development of new therapeutic 
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strategies (Chapter 4 and 5). Chapter 2 reports the development of a new 
molecular diagnostic method of bovine babesiosis denominated seminested hot-
start PCR, using 117 field samples from Mozambican cattle, and based on the 
amplification of the aspartic protease babesipsin-1 gene. In Chapter 3, the current 
status of bovine babesiosis in Mozambique was further studied using the 
seminested hot-start PCR and the RLB assay to detect infections with B. bigemina 
and B. bovis in 477 samples from 5 different farms located in Maputo Province. 
Chapter 4, describes the identification of all the genes from the cysteine protease 
family C1 in the B. bigemina genome and the relationships with genes of the same 
family in the Piroplasms. For the first time, the activity of a cysteine protease from 
Piroplasms is reported. Recombinant babesipain-1 was expressed and purified as a 
soluble fusion protein with GST, and showed activity against peptide substrates. 
With this strategy, the amount of active enzyme produced was insufficient to 
proceed with further characterization. The production of sufficient amount was 
achieved with the purification of the insoluble GST-babesipain-1 fusion protein 
and the consequent refolding, activation and biochemical characterization as 
described in Chapter 5. In the final chapter, Chapter 6, the findings of the study 
described here are discussed and future potential studies are elaborated. 
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2.1. Introduction 
Babesiosis is a tick borne disease (TBD) caused by parasites of the genus Babesia, 
with considerable worldwide economic, medical, and veterinary impact. In recent 
years, efforts have been made to rebuild the livestock population in Mozambique. 
Cattle have been imported mostly from the neighbouring countries Zimbabwe and 
South Africa. The success of this approach is being impaired by high mortality 
among the imported cattle, which is estimated at around 50% within the first year 
(Alfredo et al., 2005). Tick Borne Diseases, particularly babesiosis, anaplasmosis 
and cowdriosis are arguably the major causes of mortality. Although the 
distribution and prevalence of TBDs in Mozambique is mostly unknown, 
seroprevalence of Babesia bovis (39%) and Anaplasma marginale (63%) was 
recently reported for Tete province (Alfredo et al., 2005). 
Bovine babesiosis in Africa, and particularly in Mozambique, is caused by B. bovis 
and B. bigemina (Uilenberg, 2006). There are reports of B. occultans in South Africa 
(Gray and De Vos, 1981) and possibly Nigeria (Dipeolu and Amoo, 1984), but the 
prevalence and distribution of this benign form of cattle babesiosis is unknown. On 
the other hand, the tick vector responsible for the transmission of B. occultans, 
Hyalomma marginatum rufipes, was identified in Mozambique, suggesting that B. 
occultans may therefore be present. In vitro cultivation of B. occultans was already 
accomplished (Van Niekerk and Zweygarth, 1996), but unfortunately there are no 
published sequences of B. occultans in the public databanks, and there is also no 
Polymerase Chain Reaction (PCR) detection method available. Nevertheless, 
molecular studies should consider the presence of this and possibly other 
unidentified species. Detection methods based on the 18S rRNA gene sequence or 
other genus conserved sequences, can originate false positives as these sequences 
are expected to be more conserved with the sequences from unsequenced and 
unidentified Babesia spp.. 
B. bovis was detected in Mozambique by serologic tests (Alfredo et al., 2005), but 
these methods are less sensitive and specific in the detection of the carrier state of 
animals and do not usually distinguish between past exposure and present 
infections. PCR based techniques constitute an alternative method for the direct 
detection of Babesia in carrier cattle. The carrier state occurs after acute or 
Development of a new molecular diagnostic method for the detection of bovine 
babesiosis, its application in Mozambique 
22 
 
primary infections, in which the animals are not clinically ill. Identification of 
carrier animals is important for the assessment of infection risk, given that they 
serve as reservoirs for infection of ticks and, ultimately, wider infection of the herd 
(Calder et al., 1996). 
Several PCR based methods have been published that allow the detection of B. 
bovis and B. bigemina. More specifically, two methods have been used by various 
authors for the detection of Babesia from blood and ticks: the multiplex nested PCR 
(nPCR) for the detection of B. bovis and B. bigemina (Figueroa et al., 1993; Almeria 
et al., 2001; Gayo et al., 2003; Oliveira et al., 2005; Costa-Júnior et al., 2006) and the 
reverse line blot hybridization assay (RLB) (Gubbles et al., 1999; Georges et al., 
2001; Brígido et al., 2004; Oura et al., 2004). Both methods appear to have similar 
sensitivities at 10-6 % parasitaemia (Gubbles et al., 1999; Costa-Júnior et al., 2006). 
However, it is interesting that the non-multiplex nPCR has an increased detection 
of 10-7 % parasitaemia (Oliveira-Sequeira et al., 2005). 
The nPCR is a modification of the PCR procedure designed to increase the 
sensitivity. This modification consists of two sets of primers directed against the 
same target, used in two consecutive runs of PCR. The first set of primers is 
selected in the usual manner, whereas the second set of primers are localized 
internally or nested to the product of the first PCR run. A variation of the nPCR is 
the seminested PCR, where the second set of primers incorporates one of the 
primers of the first set (Winn Jr., 2006). 
In this chapter, we report the successful development of a new method for the 
detection of B. bovis and B. bigemina in field samples and in face of the results the 
state of bovine babesiosis in Mozambique will be briefly addressed. 
 
 
2.2. Materials and methods 
2.2.1. Blood samples from cattle 
A total of 117 blood samples were collected from cattle in the province of Maputo, 
Mozambique. The samples were collected in September near Umbelúzi in the 
Boane District, mainly from Friesian cattle. Approximately 2–4 ml of blood were 
collected from the coccygeal vein into ethylenediaminetetraacetic acid (EDTA) 
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buffered vacutainer tubes. Samples were kept at 4 °C while being transported to 
the laboratory at the Faculty of Veterinary of Maputo. The blood was stored at -20 
°C until DNA extraction. 
 
2.2.2. DNA extraction 
DNA extraction was performed according to Centeno-Lima et al. (2003). Two 
hundred microlitres of EDTA buffered whole blood was added to 500 μl 
phosphate-buffered saline (PBS), vortexed for 10 s and then centrifuged at 16000 g 
for 5 min. The cells pellet was washed with PBS three more times or until the 
supernatant was clear. The pellet was then ressuspended with 100 μl of lysis 
buffer [50 mM KCl, 0.5% (v/v) Tween-20, 10 mM Tris-HCl (pH 8.0) and 10 μg of 
proteinase K added before use], incubated overnight in a water bath at 56 °C and 
heated for 10 min at 100 °C to inactivate proteinase K. Samples were stored at -20 
°C. 
 
2.2.3. PCR reactions 
2.2.3.1. Primers 
The primers used in hot-start PCR amplification (Table 2.1), are localized within 
the putative aspartic proteinase babesipsin genes from both B. bovis and B. 
bigemina. The babesipsin putative gene sequences were identified in the Sanger 
Institute databases: in the B. bovis EST Sequencing Project (de Vries et al., 2006) 
and in the B. bigemina genome project (http://www.sanger.ac.uk/Projects/). 
The oligonucleotide primers were designed using the online GeneFisher program 
(Giegerich et al., 1996) with the following parameters: G+C content from 40 to 
60%, melting temperature between 60 and 80 °C, and primer size between 27 and 
31 bp (Table 2.1). The expected size using babesipsin primers in hot-start PCR is 
614 bp for B. bigemina and 426 bp for B. bovis. The amplification products span 2 
partial exons and 1 intron. The seminested hot-start PCR products have the 
expected size of 469 bp and 275 bp respectively for B. bigemina and B. bovis. 
The primer sequences described by Figueroa et al. (1993) were used in nPCR; 
BoF/R and BilA/B the outer primers, BoFN/RN and BilAN/BN the inner or nested 
primers (Table 2.1). 
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Melting temperatures were calculated using the Wallace–Itakura rule (Wallace et 
al., 1979). 
 
Table 2.1. Primers sequence and melting temperature (Tm). 
Method and 
parasite 
Name Primer sequence (5´-3´) Length 
(bp) 
Tm 
 (°C) 
hot-start PCR 
B. bigemina 
BigBAF1 GGGAGATAAAAATCGGCACGCCCCCGCAA 29 66 
BigBAR1 GAGGATCTATGCCTCCTAACATTATCCGTGA 31 62 
BigBAR2 GCATTCCGGGAACACTGCTCATTTCTGGGA 30 64 
hot-start PCR 
B. bovis 
BovBAF1 CCCGCTCTGGATACCGTAACCATAGGAGA 29 64 
BovBAR1 ATACTGAGGATCCACTCCGCCTAGCATCA 29 63 
BovBAR2 GCATTCCGGGTATGCTACTCATCTCTGGA 29 63 
nPCR 
B. bigemina 
BiIA CATCTAATTTCTCTCCATACCCCTCC 26 58 
BiIB CCTCGGCTTCAACTCTGATGCCAAAG 26 61 
BiIAN CGCAAGCCCAGCACGCCCCGGTGC 24 69 
BiIBN CCGACCTGGATAGGCTGTGTGATG 24 61 
nPCR 
B. bovis 
BoF CACGAGGAAGGAACTACCGATGTTGA 26 60 
BoR CCAAGGAGCTTCAACGTACGAGGTCA 26 61 
BoFN TCAACAAGGTACTCTATATGGCTACC 26 56 
BoRN CTACCGAGCAGAACCTTCTTCACCAT 26 60 
 
2.2.3.2. Babesipsin hot-start PCR and seminested hot-start PCR 
The babesipsin hot-start PCR reaction mixtures (20 μl) contained 16 mM 
(NH4)2SO4, 67 mM Tris-HCl (pH 8.8), 0.01% (v/v) Tween-20, 2.5 mM MgCl2, 0.5 μM 
each primer F1 and R1, 200 μM each dNTP, 1 U of Superhot Taq DNA polymerase 
(Bioron GmbH), and 1 μl total DNA. Hot-start PCR was carried out in a PTC-200 MJ 
Research thermocycler for 40 cycles. Each cycle consisted of 20 s of denaturation 
at 95 °C (1 min for the first cycle), 30 s of annealing at 69 °C, and 45 s of extension 
at 72 °C. The same conditions of the first PCR were used in seminested hot-start 
PCR apart from using the inner reverse primers R2 instead of R1, 1 μl of the first 
PCR products as template and an annealing temperature of 69 °C for B. bovis and 
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71 °C for B. bigemina. Only the samples that were negative in the first hot-start PCR 
were submitted to seminested hot-start PCR. Twenty random PCR products were 
gel purified and sequenced in outsourcing at STAB Vida, Portugal. 
 
2.2.3.3. nPCR 
The first PCR using the primers described by Figueroa et al. (1993), was carried 
out using the same buffer as described for babesipsin hot-start PCR, 1 U DFS-Taq 
DNA polymerase (Bioron GmbH), 0.5 μM outer primers, 1 μl total DNA and the 
thermocycler program described by Oliveira et al. (2005): 35 cycles (1 min at 95 
°C, 1 min at 60 °C for B. bovis and 64 °C for B. bigemina, 1 min 30 s at 72 °C) and a 
final extension step at 72 °C for 5 min. The same conditions of the first PCR were 
used in nPCR apart from using inner primers, 2 μl of the first PCR products as 
template and an annealing temperature of 65 °C for B. bovis and 70 °C for B. 
bigemina. 
 
2.2.4. Analysis of PCR products 
Ten microlitres of first PCR and 5 μl of second PCR products were separated by 
electrophoresis in 1.2% (w/v) agarose gel containing ethidium bromide in 0.5 x 
TBE buffer (44.5 mM Tris-HCl, 44.5 mM Boric Acid and 1 mM EDTA, pH 8.3). After 
electrophoresis, PCR products were visualized by transillumination with UV light. 
 
2.2.5. Statistical analysis 
The data obtained from DNA amplification (nPCR and seminested hot-start PCR) 
was used for comparisons among methods by Kappa coefficient analysis, a 
statistical measure of concordance for qualitative items, that takes into account the 
agreement occurring by chance. 
 
 
2.3. Results 
2.3.1. Hot-start PCR 
The combinations using the babesipsin primers described in this study and 
genomic DNA (kindly provided by Dr. Varda Shkap from Kimron Veterinary 
Institute, Israel), allowed the amplification of single band products with the 
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expected size. There was no cross reaction between primers for one species and 
genomic DNA of the other species. And even if it occurs with other isolates, it is 
expected that the amplification products will have different sizes, since there is an 
intron between the locations of the primers that is 200 bp shorter for B. bigemina. 
Hot-start PCR using field samples also allowed the amplification of single band 
products with the expected size (see Fig. 2.1 and 2.2). 
 
 
Figure 2.1. Hot-start PCR of B. bigemina DNA from random samples (1 to 10). DNA 
was subjected to hot-start PCR for the babesipsin 614 bp sequence amplification 
using the primers BigBAF1 and BigBAR1. Samples 3, 5 and 6 were negative and the 
remaining were positive. M: 100 bp DNA ladder marker; b: no DNA, negative 
control. 
 
After the seminested hot-start PCR (see Fig. 2.3 and 2.4), 14 samples that were 
negative in the first PCR were positive for B. bigemina, and 15 were positive for B. 
bovis. Thus, the detection of B. bigemina and B. bovis after the seminested hot-start 
PCR increased and were respectively 90% and 80%. The mixed infections also 
increased to 86 samples (74%) and the number of negatives for both Babesia 
decreased to 2 (1.7%). Only one strong amplification with a different size was 
observed in the B. bigemina seminested hot-start PCR, and was considered as 
negative (Fig. 2.3, sample 2). 
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Figure 2.2. Hot-start PCR of B. bovis DNA from random samples (1 to 10). DNA was 
subjected to hot-start PCR for the babesipsin 426 bp sequence amplification using 
the primers BovBAF1 and BovBAR1. Samples 5 and 9 were negative and the 
remaining were positive. M: 100 bp DNA ladder marker; b: no DNA, negative 
control. 
 
 
 
Figure 2.3. Seminested hot-start PCR of B. bigemina DNA from random samples (1 
to 10). DNA was subjected to seminested hot-start PCR for the babesipsin 469 bp 
sequence amplification using the primers BigBAF1 and BigBAR2. Samples 2, 3 and 
7 to 10 were negative and the remaining were positive. M: 100 bp DNA ladder 
marker; b: no DNA, negative control. 
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Figure 2.4. Seminested hot-start PCR of B. bovis DNA from random samples (1 to 
10). DNA was subjected to seminested hot-start PCR for the babesipsin 275 bp 
sequence amplification using the primers BovBAF1 and BovBAR2. Samples 3, 5, 7, 
8 and 10 were negative and the remaining were positive. M: 100bp DNA ladder 
marker; b: no DNA, negative control. 
 
 
2.3.2. nPCR 
All 117 samples were analyzed by nPCR for comparison with the hot-start PCR 
method. The nPCR reactions using the primers described by Figueroa et al. (1993), 
resulted in amplification from field samples of the desired products, but showed 
some unspecific background amplification when using B. bigemina primers (see 
Fig. 2.5). The unspecific amplification was in the same range as the desired 
product, making difficult the interpretation of results, mainly for positive samples. 
The unspecific amplification can be reduced using half the volume of template in 
the nPCR (1µl), but the detection decreased in less two positive samples, when all 
the samples were analysed with this modification. There was no amplification in 
the first PCR (not even using hot-start polymerase), most possibly due to low 
concentrations of parasite DNA template. In the second or nPCR, 90 samples were 
positive for B. bigemina (77%) and 91 were positive for B. bovis (78%). 
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Figure 2.5. Nested PCR of B. bigemina DNA from random samples (1 to 10). DNA 
was subjected to nested PCR for the 169 bp sequence amplification using the 
primers BiIAN and BiIBN. Samples 3, 5, and 6 were negative and the remaining 
were positive. M: 1kbp DNA ladder marker; b: no DNA, negative control. 
 
2.3.3. Statistical analysis 
In comparison with the nPCR method, the seminested hot-start PCR allowed an 
increased detection for both B. bigemina and B. bovis. Some samples were only 
positive using the seminested hot-start PCR method, and some were only positive 
using the nPCR. Despite this, the observed mutual agreement between the two 
methods is relatively high: 0.829 in the detection of B. bigemina and 0.846 in the 
detection of B. bovis. The Kappa coefficient determined for the two detection 
methods of B. bigemina (0.412) was lower than for the detection methods of B. 
bovis (0.515).  
 
 
2.4. Discussion 
Babesiosis and other TBD´s may be responsible for severe economic losses in 
Mozambique, but little is known about the epidemiology of these diseases in this 
country. Here we report for the first time the direct detection of B. bigemina and B. 
bovis in field samples from Mozambique. Bovine babesiosis was detected by 
seminested hot-start PCR, in 90% of cattle with B. bigemina and in 82% with B. 
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bovis. It’s also important to note that almost the entire herd was positive (98%) for 
B. bigemina and/or B. bovis. These results clearly indicate that this region of 
Mozambique is endemic for bovine babesiosis. Similar results were observed by 
Oliveira et al. (2005) in São Carlos, SP, Brazil, where they detected infection in 
cattle by B. bigemina (88%) and B. bovis (92%) using the nPCR. Although other 
studies should be conducted in other areas in Mozambique to confirm the endemic 
status of babesiosis in this country, efforts to rebuild the stock population should 
consider the babesiosis threat, especially when importing cattle from countries 
that adopt stricter control measures. 
 
Table 2.2. Comparison of methods used for the detection of cattle infected with B. 
bigemina and/or B. bovis in Boane district, Mozambique. 
Method B. bigemina B. bovis Mixed infections No infection 
PCR 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
nPCR 90 (77%) 91 (78%) 73 (62%) 7 (6.0%) 
hot-start PCR  90 (77%) 82 (70%) 61 (52%) 6 (5.1%) 
seminested hot-start PCR  104 (90%) 97 (82%)  86 (74%)  2 (1.7%) 
 
There are several reported methods in the literature describing the detection of B. 
bigemina and B. bovis, but only some have been tested with random field samples: 
the nPCR (Figueroa et al., 1993; Almeria et al., 2001; Gayo et al., 2003; Oliveira et 
al., 2005; Costa-Júnior et al., 2006), the RLB (Gubbles et al., 1999; Brígido et al., 
2004; Oura et al., 2004) and more recently the LAMP assay (Iseki et al., 2007). All 
three methods have sensitivities around 10-6 % parasitaemia (Gubbles et al., 1999; 
Costa-Júnior et al., 2006; Iseki et al., 2007), although Iseki and co-workers (2007) 
reported a lower sensitivity for the nPCR (10-4 % to 10-5 % parasitaemia) in their 
comparative study with the LAMP assay. 
In this study the seminested hot-start PCR was more sensitive than the nPCR 
(Table 2.2), although the kappa coefficients determined to compare the two assays 
indicate moderate agreement (0.412 and 0.515) and the observed mutual 
agreement between methods is relatively high (0.829 and 0.846). The 
disagreement between methods is not only the consequence of different detection 
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values. It is also the result of the observation that some samples were only positive 
using the seminested hot-start PCR method, and some were only positive using the 
nPCR. This error associated with each method can be expected when the samples 
have low parasitaemias, because the frequency of detection decreases with the 
decrease in parasitaemia (Calder et al., 1996). More significant, are the differences 
between methods in the first PCR (Table 2.2). The hot-start PCR improved 
considerably the detection in the first PCR, and this is a major advantage of this 
method. Unfortunately the primer pairs used didn’t allow an improved detection 
between the first hot-start PCR and the nPCR. But the B. bigemina primer pair used 
in the first hot-start PCR showed the same sensitivity as the two step nPCR (Table 
2.2). Other primer pairs could even increase the detection limit in the first hot-
start PCR, especially if the target gene is changed to a multicopy gene instead of the 
apparent single copy babesipsin gene. With the release of the complete and 
annotated B. bovis and B. bigemina genomes, it will be possible to verify if there are 
multicopy genes suitable for this intra genus analysis. The 18s rRNA multicopy 
gene, is an alternative, but this gene is less variable and there is still no sequence 
information for B. occultans. 
In the first PCR of the nPCR method, using BoF and BoR or BilA and BilB primers, 
there was no amplification, even when using hot-start polymerase. When using the 
babesipsin longer primers with higher melting temperatures (Table 2.1) and a non 
hot-start polymerase, there was also no amplification. Only the combination of a 
hot-start polymerase and long primers (29-31 bp) allowed the amplification from 
field samples with low concentrations of parasite DNA. This observation indicates 
that this combination increases the sensitivity of the PCR, probably by increasing 
the specificity. The use of hot-start polymerases and 30 bp primers with melting 
temperatures around 64 °C can eventually be used in the development of new 
detection methods for pathogens that are present in low numbers as in the case of 
the carrier state of B. bovis and B. bigemina. 
In conclusion, our new method allowed the detection of B. bigemina and B. bovis in 
field samples from Mozambique and can now be used in further epidemiological 
studies to elucidate the endemic status of babesiosis in Mozambique. 
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3.1. Introduction 
Bovine babesiosis is a tick-borne disease (TBD) of cattle caused in Mozambique by 
the protozoan parasites Babesia bigemina and B. bovis. Bovine babesiosis is of 
great veterinary importance as this TBD cause severe economic losses throughout 
the world (Bock et al., 2004). In trypanosome free regions, TBDs are considered 
the main cause of morbidity and mortality of cattle in Mozambique, although the 
information on TBDs in the country requires an urgent update. Recently, two 
epidemiological studies on bovine babesiosis in Mozambique have been published: 
Babesia bovis (39%) was detected in a serological survey in Tete province (Alfredo 
et al., 2005); and, bovine babesiosis was detected in Maputo province using a new 
seminested hot-start PCR method (Chapter 2) that showed improved detection 
over a previous nested PCR method (Figueroa et al., 1993). 117 random field 
samples from one farm located in Maputo province were analysed by the 
seminested hot-start PCR and both B. bigemina and B. bovis were detected in over 
80% of the samples (Chapter 2). These results indicated that the area of Maputo 
province, Mozambique, could be endemically stable for these species of bovine 
babesiosis. In the current chapter, the detection of bovine babesiosis by the 
seminested hot-start PCR and the reverse line blot (RLB) assay (Gubbels et al., 
1999; Schouls et al., 1999; Bekker et al., 2002) in five farms geographically 
distributed in Maputo province is reported. The RLB assay is based on a reverse 
hybridization where the specific probes are immobilized to a solid support and the 
sample is denatured and subsequently allowed to hybridize with the probes. The 
RLB assay was also used to determine the presence of haemoparasites of the 
genera Babesia, Theileria, Anaplasma and Ehrlichia. 
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3.2. Materials and methods 
3.2.1. Cattle 
Blood samples were collected randomly from 
cattle in five different locations in the 
province of Maputo, Mozambique (Fig. 3.1): 
117 samples in September near Umbelúzi, 
Boane district; 77 samples in July near Bela 
Vista, Matutuine District; 95 samples in 
October in Catuane, Matutuine District; 93 
samples in October in Chobela, Magude 
District; and 95 samples in November in 
Namaacha, Namaacha District (Friesian cattle 
in Umbelúzi, and in the remaining farms 
Nguni and Nguni crosses). Blood was 
collected and processed as described 
elsewhere (Chapter 2). 
Figure 3.1. Map of the locations 
in Maputo province, Mozambique 
where samples were collected. 
 
3.2.2. DNA extraction 
DNA extraction was carried out as described previously (Chapter 2). Briefly, 
whole blood was washed with phosphate-buffered saline (PBS), and the remaining 
cells pellet were lysed in an appropriate buffer with Proteinase K, overnight at 56 
°C. 
 
3.2.3. Hot-start PCR and seminested hot-start PCR 
Hot-start PCR was performed as described previously (Chapter 2) with minor 
changes. Hot-start PCR reaction mixtures (20 μl) contained 5 mM (NH4)2SO4, 15 
mM Tris-HCl (pH 8.2), 30 mM KCl, 2.5 mM MgCl2, 0.02% (w/v) bovine serum 
albumine, 0.5 μM each primer F1 and R1, 200 μM each dNTP, 0.025 U of 
DyNAzymeTM II Hot Start DNA polymerase (Finnzymes Oy, Espoo Finland), and 2 μl 
of DNA. Hot-start PCR was executed for 40 cycles: 30 s of denaturation at 94 °C (10 
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min in the first cycle to activate the hot start polymerase), 30 s of annealing at 68 
°C, and 45 s of extension at 72 °C. Negative samples in the first hot-start PCR were 
submitted to seminested hot-start PCR, using the conditions of the first PCR with 
the inner reverse primers R2 in substitution of R1, and 1 μl of the first PCR 
products as template. PCR products were examined in ethidium bromide-stained 
agarose gels. 
 
3.2.4. Reverse line blot assay 
The PCR products that were later hybridized with the probes in the RLB 
membrane were amplified with two sets of primers. For the identification of 
Babesia and Theileria species a fragment of 460–540 bp of the 18S SSU rRNA gene 
spanning the V4 region was amplified with primers described by Gubbels et al. 
(1999). For the identification of Anaplasma and Ehrlichia species a PCR product of 
492–498 bp fragment of the 16S rRNA gene spanning the V1 region was amplified 
using primers described by Bekker et al. (2002). Primers were obtained from 
Isogen Life Science (Maarsen, The Netherlands). PCR amplification was performed 
in a 25 µl reaction volume consisted of 2.5 U Taq DNA polymerase (Invitrogen, 
USA), 1x PCR buffer, 50 pmol of each primer, 200 µM each dNTP and 2.5 µl of the 
template DNA with an automated cycler (I-Cycler, Bio-Rad) for 50 cycles: 10 cycles 
of 94°C for 20 s, 67°C for 30 s, and 72°C for 30 s, with a 2°C decrease of the 
annealing temperature every second cycle (touchdown); and forty cycles of 94°C 
for 20 s, 57°C for 30 s, and 72°C for 30 s. The RLB membrane with 34 species 
specific amino-linked oligonucleotide probes from Isogen Life Science (Maarssen, 
The Netherlands) was hybridized with the PCR products according to Nijhof et al. 
(2005). Each membrane was used for a maximum of 10 times. 
 
3.2.5. Cloning of 18S ribosomal RNA genes 
The partial Babesia spp. 18S rRNA genes were amplified by PCR. A PCR product 
with the expected size of approximately 430 bp was obtained with primers specific 
for Babesia spp. (Hilpertshauser et al., 2006). A longer PCR product with 
approximately 790 bp and a shorter product with 350 bp were respectively 
amplified using forward primers 5-22F and 455-479F with the reverse primer 
793-772R (Birkenheuer et al., 2003). PCR products were cloned into the plasmid 
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vector pCR2.1 (Invitrogen), and positive clones were sequenced at STAB Vida 
(Oeiras, Portugal). Eleven unique sequences obtained in this study were submitted 
to GenBank under accession nos. FJ869895 to FJ869905. Multiple nucleic sequence 
alignment between 18S rRNA genes was performed using ClustalW (Thompson et 
al., 1994), followed by manual editing in Bioedit (Hall, 1999) and phylogenetic 
relationships constructed and visualized by MEGA4 program (Tamura et al., 2007). 
 
 
3.3. Results 
3.3.1. Seminested hot-start PCR 
Detection levels of Babesia species differed considerably in the five farms studied. 
B. bigemina detection by the seminested hot-start PCR varied between a minimum 
of 30% and a maximum of 89%, with an overall detection of 61%. B. bovis 
detection changed between 27% and 82%, with an overall frequency of 53%. B. 
bovis was only detected in higher levels than B. bigemina in the Namaacha farm. A 
high percentage of the herds from the five farms were infected with either parasite, 
and only 25% of the 477 samples were negative for infection with bovine 
babesiosis. Mixed infections were common, with 37% of the cattle infected by both 
Babesia species. Considering only the results obtained in this study (excluding 
Umbelúzi farm), the seminested improved the detection over the first hot-start 
PCR in 2% for B. bigemina and in 11% for B. bovis. 
 
3.3.2. Reverse line blot assay 
The RLB hybridization method allowed the identification of ten different species of 
four genera of haemoparasites present in the region of Maputo province (Table 
3.1). B. bovis was detected in four of the five farms, but in much lower percentages 
compared with the results obtained by the seminested hot-start PCR. B. bigemina 
was not detected by the RLB method. In Chobela, 3% of the samples tested positive 
for B. vogeli, known for infections in domestic dogs. Anaplasma bovis and Theileria 
taurotragi were detected in only two farms, whereas the other detected 
haemoparasites were widely distributed. The most frequently detected species 
using the RLB were T. velifera and T. mutans, present in respectively 54% and 52% 
of the samples. 
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Table 3.1. Prevalence of cattle haemoparasites infections in Maputo province, 
Mozambique. 
 
District Boane Magude Matutuine Namaacha 
 
Location Umbelúzi Chobela Bela Vista Catuane Namaacha 
 
Month September October July October November 
 
Breed Friesian Nguni and Nguni crosses 
 
nº samples 117 93 77 95 95 
hot PCR B. bigemina 76.9%a 67.8% 29.9% 53.7% 51.6% 
B. bovis 70.1% a 43.0% 22.1% 21.1% 54.7% 
seminested 
hot PCR 
B. bigemina 88.9% a 72.0% 29.9% 55.8% 54.7% 
B. bovis 82.9% a 54.8% 27.3% 32.6% 68.4% 
mixed 
infections 
73.5% a 44.1% 10.4% 20.0% 38.9% 
no detection 1.7% a 17.2% 55.8% 31.6% 15.8% 
RLB 
B. bigemina 0.0% 0.0% 0.0% 0.0% 0.0% 
B. bovis 17% 2.2% 2.6% 0.0% 4.2% 
B. vogeli 0.0% 3.2% 0.0% 0.0% 0.0% 
T. mutans 42.3% 69.9% 71.8% 22.1% 55.8% 
T. velifera 70.5% 51.6% 70.5% 23.2% 51.6% 
T. taurotragi 3.8% 0.0% 0.0% 0.0% 1.1% 
T. spp. Sable 11.5% 26.9% 3.8% 0.0% 1.1% 
A. centrale 6.8% 10.8% 0.0% 1.1% 2.1% 
A. marginale 23.9% 10.8% 7.7% 0.0% 1,1% 
A. bovis 3.3% 1.1% 0.0% 0.0% 0.0% 
E. spp. 
Omatjenne 
12.8% 14.0% 0.0% 1.1% 2.1% 
a – from Chapter 2. 
 
 
3.3.3. 18S ribosomal RNA gene sequences analysis 
Six different sequences of the B. bigemina 18S rRNA gene were obtained from 
samples collected at Chobela farm (Chobela1 to 6 with GenBank accession nos. 
FJ869900 to FJ869905) using the primers described by Hilpertshauser et al. 
(2006). The most divergent isolate of the Mozambican isolates, Chobela1, was 
amplified from two different samples, and shows three mismatches and 99% 
identity with several previously submitted sequences in a BLAST search. The 
isolates Chobela2, Chobela3 and Chobela4 are 99% identical with a B. bigemina 
isolate identified in China (GenBank accession no. AY603402). Chobela5 and 
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Chobela6 are both 99% identical with isolates from Kenya (GenBank accession no. 
EF458200) and Argentina (GenBank accession no. EF458191). An alignment with 
the B. bigemina 18S ribosomal RNA gene sequences and the B. bigemina RLB probe 
was constructed (Fig. 3.2). The sequences from the Mozambican isolates have 
three mismatches in the region of the species specific probe used in the RLB assay. 
 
 
Figure 3.2. Alignment of worldwide B. bigemina 18S rRNA gene sequences with 
the respective species-specific RLB probe. GenBank accession nos. provided next to 
the locations of isolates. 
 
Several sequences of the 18S rRNA gene from Theileria spp. were also amplified 
and cloned using the primers described by Birkenheuer et al. (2003). Amplified 
from two samples, Theileria sp. MSD/Chobela (GenBank accession no. FJ869895) is 
99% identical with Theileria sp. “strain MSD” from South Africa (GenBank 
accession no. AF078816). Two similar isolates, T. velifera Chobela1 and Chobela2 
(GenBank accession nos. FJ869896 and FJ869897), show 99% identity with T. 
velifera from Tanzania (GenBank accession no. AF097993). Two other homologous 
isolates, T. mutans Chobela1 and Chobela2 (GenBank accession nos. FJ869898 and 
Chapter 3 
41 
 
FJ869899), are 99% identical with T. mutans from Kenya (GenBank accession no. 
AF078815). A phylogenetic tree with the Theileria spp. sequences was constructed 
(Fig. 3.3). 
 
 
Figure 3.3. Phylogenetic tree inferred from Theileria spp. 18S rRNA gene 
sequences. Tree constructed using the UPGMA method (Sneath and Sokal, 1973), 
with superimposed bootstrap values (Felsenstein, 1985). GenBank accession nos. 
provided next to the names. 
 
 
3.4. Discussion 
In this study, the prevalence and the distribution of bovine babesiosis infections 
are reported for cattle from Maputo province (26,058 km²) which shares borders 
with the countries Swaziland and South Africa, being the latest the main origin of 
imported cattle. Both bovine babesiosis infecting parasites, B. bigemina and B. 
bovis, were detected by the seminested hot-start PCR in high frequency in four of 
the five locations studied. Detection of infection with B. bigemina ranged between 
30% and 89% (61% total), and infection with B. bovis between 27% and 82% 
(53% total). The results obtained in Maputo province are comparable to the 
serological results obtained in Tete province where 39% of all calves were 
seropositive to B. bovis, raging between farms from 17% to 71% (Alfredo et al., 
2005). Since the five farms are geographically well distributed in Maputo province, 
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we can conclude that these Babesia spp. are common and endemic in this region of 
southeast Africa although there are low prevalence areas. It was estimated that 
when the majority of calves are exposed to B. bovis infection (at least 75%) by 6 to 
9 months of age the disease incidence is very low and a state of natural endemic 
stability is present (Mahoney, 1974). In all the farms except for the Umbelúzi farm, 
all the detection values by the seminested hot-start PCR for Babesia spp. were 
below 75%. Therefore the results suggest that bovine babesiosis in Mozambique is 
not in a situation of endemic stability. 
A higher prevalence of infections with Babesia spp. was observed in the Umbelúzi 
farm, and this may be related to the breed of cattle. The European Friesian breed at 
Umbelúzi is considered more susceptible than the African Nguni breed and Nguni 
crosses (Bock et al., 2004) present in the remaining locations. Detection frequency 
of cattle with Babesia spp. was above 50% in Maputo Province, whereas in the 
farm of Bela Vista, both species were detected with the lowest frequency of around 
30%. In contrast with the other farms, Bela Vista has a higher relative humidity 
since it is located in the coastland, in the delta of Maputo River. A higher relative 
humidity contributes positively to the activity and longevity of the ticks as it 
prevents desiccation (Sutherst et al., 2006), and this appears contrary to what was 
observed. Other factors may be contributing to a lower frequency of babesiosis in 
Bela Vista. In this farm there are also current trypanosomiasis cases, and many 
drugs used against Trypanosoma spp. also show activity against babesiosis 
(Mamman et al., 1993; Zintl et al., 2003). In Bela Vista, samples were collected in 
late July, and the collection in other locations was done more than one month later, 
and this may also have contributed to differences in prevalence of infection with 
Babesia parasites, since babesiosis infections can change on a seasonal basis (Bock 
et al., 2009). Another exception to the overall results was observed in Namaacha. 
Only in this farm, B. bovis (68%) was detected in higher frequency than B. bigemina 
(55%). Namaacha is located at moderate altitude (approximately 600 meters 
above sea level), with temperatures lower than those of the other farms, all located 
at sea level. This environmental factor may contribute to a major change in the 
challenge with tick species and in consequence with Babesia spp., but further 
studies are needed to confirm this hypothesis. 
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In acute babesiosis, B. bovis infections have lower parasitaemias when compared 
with B. bigemina (Shkap et al., 2005). In the carrier or persistent state, 
parasitaemia can decrease below 10-8% for B. bovis (Calder et al., 1996), and the 
level of parasitaemia in B. bigemina is probably higher than that of B. bovis and B. 
divergens (Gubbels et al., 1999). Our results, showed that the seminested hot-start 
PCR improved the sensitivity over the first hot-start PCR. And it improved more 
the detection of B. bovis (11%) than of B. bigemina (2%). This result appears to 
confirm previous indications that B. bovis is present in lower parasitaemias, since 
only the more sensitive seminested hot-start PCR allowed the detection of  
infection by B. bovis in a significant number of samples. 
The haemoparasites detected in higher frequency by the RLB were T. mutans 
(52%) and T. velifera (54%). Similar results were obtained by Oura et al. (2004) in 
a survey conducted in Uganda. In that study, bovine babesiosis was detected by the 
RLB in low numbers, with 2% for B. bigemina and 0% for B. bovis. In the present 
study, B. bovis infections were detected by the RLB between 0% and 17%, and B. 
bigemina infections were not detected by the RLB technique, in contrast with the 
high frequency of detection by the seminested hot-start PCR. Even if, Gubbels et al. 
(1999) demonstrated that there was no PCR competition in the RLB assay between 
genomic DNA of B. bovis and T. annulata, field samples are much more complex 
with several parasites present at the same time, and with varying proportions 
between them. In this study, it was found that five different species of the genera 
Theileria and Babesia infected the same host simultaneously. Therefore, it is 
possible that PCR competition occurs and this may explain in part the low 
sensitivity of the RLB assay compared do the seminested hot-start PCR. To better 
understand the divergent results obtained by the two methods we decided to look 
at the local B. bigemina 18S rRNA sequences. These results suggest another 
explanation for the low sensitivity of the RLB. In fact, the analysis of the sequences 
from the 18S rRNA gene from B. bigemina revealed that none of the Mozambican 
isolates were identical to the oligonucleotide probe described by Gubbels et al. 
(1999) and used to identify B. bigemina in the RLB assay (Fig. 3.2). All the 18S 
rRNA gene sequences obtained in this study show three mismatches with the 
oligonucleotide RLB probe. This degree of dissimilarity is enough to prevent the 
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hybridization of the amplified products from B. bigemina with the RLB probe and 
to originate false negatives, as three mismatches also allows differentiation 
between species in the RLB assay (Molano et al., 2004; Nindl et al., 2007). Isolates 
from China (GenBank accession no. AY603402), Kenya (GenBank accession no. 
EF458200) and Argentina (GenBank accession no. EF458191) are identical to the 
Mozambican isolates in the probe region (Fig. 3.2). Recently, Petrigh et al. (2008) 
reported the development of a new probe that allowed the detection of all 
Argentinean isolates studied, in contrast with the old probe described by Gubbels 
et al. (1999) that failed in the detection of half of the samples. 
In Chobela, 3% of the cattle were positive in the RLB assay for infections with B. 
vogeli, which is known to infect canids, and is transmitted by Rhipicephalus 
(Uilenberg, 2006). To our knowledge, this is the first time that B. vogeli was 
identified in cattle. Tentative attempts to amplify the B. vogeli 18S rRNA gene were 
unsuccessful, although a primer with the sequence of the RLB probe was used 
besides the ones described earlier. The products that were cloned and sequenced 
in these tentative amplifications were reported in this study or were identified as 
similar to Bos tauros. Without the confirmation from the amplification of the 18S 
rRNA gene, the question remains if the positive samples for B. vogeli by the RLB 
assay are in fact from infections by this canids Babesia or from a similar 
unidentified species, or even if it is the result of unspecific hybridization. 
The phylogenetic tree inferred from the Theileria spp. 18S rRNA genes (Fig. 3.3) 
shows the taxonomic separation between the T. mutans and T. velifera groups. 
None of the T. mutans isolates was identical to the isolates from Kenya (Chae et al., 
1999) and Sudan (Salih et al., 2007). This may be explained by microheterogeneity 
where minor nucleotide sequence differences occur in homologous regions of the 
gene (Chae et al., 1999). In this study, a Chobela isolate (GenBank accession no. 
FJ869895) was identified with 99% identity with Theileria sp. “strain MSD” 
(GenBank accession no. AF078816), that was isolated from cow blood in South 
Africa (Chae et al., 1999). These isolates are distinct from T. mutans, and T. mutans-
like1 and 2 isolated from the African buffalo (Syncerus caffer). Further studies are 
needed to clarify the identity and extension of the geographic distribution of this 
distinct Theileria sp. “strain MSD”. T. velifera is clustered together with the benign 
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parasite of deer T. cervi, and another Theileria sp. isolated from deer (Fig. 3.3). The 
isolates of T. velifera identified in this study are not identical to the previous 
reported sequence from Tanzania (Gubbels et al., 1999), reflecting the 
microheterogeneity characteristic of Theileria spp., and also observed in this study 
for T. mutans.  
The results presented in this study, show that multiple infections with several 
species of cattle haemoparasites are common in Maputo province and that bovine 
babesiosis is common and endemic in this region, and also suggest high variability 
within the species in the field. The epidemiological data reported here is 
indispensable for the assessment of the situation and to establish adequate control 
measures in Mozambique. 
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4.1. Introduction 
The heamoprotozoan parasites of the genera Babesia and Theileria are tick-
transmitted piroplasms in the phylum Apicomplexa (Bock et al., 2004; Chae et al., 
1999; Robinson, 1982; Uilenberg, 2006). Theileria species have a pre-erythrocytic 
development stage and invade lymphocytes first in their vertebrate hosts (Spooner 
et al., 1989). This schizogony is absent in Babesia species that only invade 
erythrocytes (Homer et al., 2000). The cattle pathogens Babesia bovis and B. 
bigemina responsible for bovine babesiosis, and Theileria annulata and T. parva 
responsible for bovine theileriosis are of veterinary importance as these tick-borne 
diseases cause severe economic losses throughout the world (Bock et al., 2004; 
Mukhebi et al., 1992). Live attenuated vaccines are used for the control of cattle 
babesiosis and theileriosis in many regions of the world, but outbreaks are 
common as the vaccines are strain-specific (Pipano and Shkap, 2000; de Waal and 
Combrink, 2006; Yin et al., 2008), suggesting major diversity within the species. 
Cysteine proteases are essential to the life cycle and pathogenicity of parasitic 
protozoa (Sajid and McKerrow, 2002) and are under study as promising drug 
targets. Cysteine proteases have numerous roles in Apicomplexa parasites such as 
catabolic functions, immunoevasion, enzyme activation, cellular invasion and 
rupture (Rosenthal, 2004; Dowse and Soldati, 2004). In piroplasms the role of 
cysteine proteases is mostly unknown, but the importance of these proteolytic 
enzymes in the life cycle of Babesia and Theileria parasites was demonstrated in 
inhibition studies. It was showed that the lipophilic cysteine protease class 
inhibitors E-64d and ALLN reduced in vitro the invasion of erythrocytes as well as 
the growth of B. bovis (Okubo et al., 2007). The growth of T. parva schizont-
infected bovine lymphocytes was also impaired by addition of Z-Leu-Val-Gly-CHN2, 
a diazomethel ketone inhibitor of CPs (Nene et al., 1990). And, Theileria (Babesia) 
equi propagation of infected erythrocytes in vitro was significantly reduced in the 
presence of the cysteine protease inhibitor E-64d (Holman et al., 2002). Hence, 
cysteine proteases of piroplasms retain their importance as potential drug targets 
for the development of reliable and safer chemotherapeutic treatments that are 
currently required for the control of babesiosis and theileriosis (Vial and Gorenflot, 
2006; Wilkie et al., 1998). 
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Complete piroplasms genome sequences for B. bovis, T. annulata, and T. parva have 
been reported (Brayton et al., 2007; Gardner et al., 2005; Pain et al., 2005), and 
sequencing of the B. bigemina genome is in active finishing 
(http://www.sanger.ac.uk/Projects/B_bigemina/). Comparative analysis of these 
complete genomes revealed a high conservation of gene sequences and synteny, 
although rearrangements have occurred, and also showed that there are unequally 
expanded gene families and species-specific genes (Brayton et al., 2007; Pain et al., 
2005). Since cysteine proteases roles in protozoa parasites are often related with 
cell invasion and rupture (Dowse and Soldati, 2004; Rosenthal, 2004), differences 
in cysteine protease genes content between Babesia and Theileria genomes may 
partially explain the ability of Theileria species to infect lymphocytes and that 
Babesia species only infect erythrocytes in the vertebrate host. Similar cysteine 
protease genes may have similar functions in both genera, and some cysteine 
protease genes may have several functions, as in other Apicomplexa parasites, like 
with falcipain-1, a papain-like cysteine protease of P. falciparum that participates 
in haemoglobin degradation and in the merozoite release (Dasaradhi et al., 2005). 
Here we report the identification of cysteine protease genes of Family C1 from B. 
bigemina and compare them with the annotated genes from the complete 
piroplasms genomes of B. bovis, T. annulata, and T. parva. We also expressed 
babesipain-1, one of the identified cysteine proteases from B. bigemina, and show 
that is a proteolytically active enzyme. 
 
 
4.2. Materials and methods 
4.2.1. Database search for similarity and alignment approaches 
A total of 2597 query protein sequences of all the annotated members of the C1 
family of papain-like cysteine proteases, retrieved from the non-redundant library 
of protein sequences (pepunit.lib) available at MEROPS (Rawlings et al., 2008) 
were used in local tblastn search for cysteine protease coding genes in the B. 
bigemina genome contigs database (dated 2008-06-26) available at The Wellcome 
Trust Sanger Institute (http://www.sanger.ac.uk/Projects/B_bigemina/). A 
threshold of E≤1e-04 was adopted for the tblastn searches (Wu et al., 2003). The 
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gene structure of identified cysteine protease genes with multiple exons was 
predicted using the FGENESH and FGENESH+ software 
(http://www.softberry.com). Global alignment of homologous chromosomes and 
contigs used LAGAN (Brudno et al., 2003) with default parameters anchored by 
predicted gene structures producing a VISTA plot (Frazer et al., 2004). Multiple 
protein sequence alignment between Piroplasmida CPs was performed using 
ClustalW (Thompson et al., 1994), followed by manual editing in Bioedit (Hall, 
1999). Phylogenetic relationships were constructed and visualized by MEGA4 
program (Tamura et al., 2007). The similarities and identities reported for an all-
against-all comparison between homologs were determined by MatGAT v2.0 
software using the default settings (Campanella et al., 2003). 
 
4.2.2. Cloning and expression of babesipain-1 
The full length babesipain-1 gene was amplified from B. bigemina genomic DNA 
(kindly provided by Dr. Varda Shkap from Kimron Veterinary Institute, Israel) by PCR 
using Taq DNA polymerase (Bioron GmbH, Ludwigshafen Germany), forward 
(BigCis1EX1- GCCCGGGAATGTCGGGAACCCGTTCGTACATG) and reverse 
(BigCis1EX2- GCTCGAGTTAGTGGGCCAGCACTGCGCCGGTT) primers which 
contained SmaI and XhoI sites (in italics) at their respective 5P-ends. The amplification 
was performed for 30 cycles of: 94 ºC for 1 min; 55 ºC for 1 min; 72 ºC for 1 min; prior 
to a final elongation step of 72 ºC for 10 min. The resultant 1392 bp product was ligated 
into the pTZ57R cloning vector (Fermentas, EU) and several clones were sequenced by 
STAB Vida (Oeiras, Portugal). Babesipain-1 nucleotide sequence was deposited at 
GenBank under the accession no. FJ859910. 
Full-length babesipain-1 was released from pTZ57R-BigCis1 by digestion with SmaI 
and XhoI and subcloned into pGEX-6P-1 expression vector (GE Healthcare, 
Buckinghamshire UK) digested with the same enzymes. Production and purification of 
recombinant glutathione S-transferase (GST) fusion protein was conducted according to 
the manual recommendations (GE Healthcare, Buckinghamshire UK). Briefly, the 
pGEX-6P-BigCis1 construct was transformed using the TransformAid
TM
 Bacterial 
Transformation System (Fermentas, EU) into E. coli BL21 (GE Healthcare, 
Buckinghamshire UK), Rosetta-gami
TM
 2 (Novagen, Madison USA) and XL1-Blue 
(Stratagene, USA) cells, and cultures were induced at an Abs 600nm of 1.0 for 2h with 
Identification of papain-like cysteine proteases from Babesia bigemina as potential 
drug targets 
52 
 
1mM isopropyl-β-D-thiogalactopyranoside (IPTG). The induced cell pellet was 
collected and lysis was performed by sonication. The soluble recombinant protein was 
purified from the lysate using Glutathione Sepharose 4B (GE Healthcare, 
Buckinghamshire UK), following the brand indications with the exception that 0.1% 
Triton X-100 was used in binding and washing steps. Fractions containing enzyme 
activity were pooled and concentrated by membrane filtration (10 kDa cut-off Vivaspin; 
Sigma-Aldrich). 
Total extracts and purification fractions were analyzed by western blotting for the 
presence of GST and GST-fusion proteins using Anti-Glutathione-S-Transferase 
(GST)–Alkaline Phosphatase Conjugate antibody (Sigma-Aldrich) as recommended by 
the manufacturer. 
 
4.2.3. Activity assays 
Babesipain-1 activity was assayed fluorimetrically as the hydrolysis of the substrates Z-
Phe-Arg-AMC (Sigma-Aldrich, St. Louis USA), Z-Leu-Arg-AMC, Z-Leu-Leu-Arg-
AMC and Z-Val-Val-Arg-AMC (Bachem Holding AG, Bubendorf Switzerland) was 
followed over time. 20 μl of enzyme solution was added to 100 mM sodium acetate (pH 
5.7) containing 50 μM fluorogenic substrate and 5 mM DTT in a final volume of 0.2 ml, 
and the release of 7-amino-4-methyl coumarin (AMC) was monitored (excitation 360 
nm, emission 460 nm) for 30 min at 37 ºC using a Fluorescence Microplate Reader 
FLx800 (BioTek Instruments Inc., USA). 
For gelatin zymography, samples were mixed with SDS-PAGE sample buffer lacking a 
reducing agent, incubated 5 min at 25 ºC and separated in a 10% (w/v) SDS-PAGE 
polyacrylamide gel, co-polymerized with 0.1% (w/v) gelatin (Heussen and Dowdle, 
1980). The gel was washed twice with 2.5% (v/v) Triton X-100 to remove SDS for 30 
min at 25 °C (Liotta and Stetler-Stevenson, 1990). Gel was then incubated overnight at 
37 °C in 100 mM sodium acetate (pH 5.7), 5 mM DTT, before staining with Coomassie 
Brilliant Blue R250. The activity band was observed as a clear colourless area depleted 
of gelatin in the gel against the blue background. 
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4.3. Results 
4.3.1. Database search for similarity, genome alignments and protein 
sequence analysis 
Five putative genes, named BbiCP1 to 5, with high homology to the query protein 
sequences of members of the C1 family of cysteine proteases, were found by 
tblastn in the unfinished B. bigemina genome database. Three are intronless genes 
(BbiCP1 to 3), and the remaining two genes have several exons (BbiCP4 and 5). 
BbiCP1, 2 and 3 have expected ORF sizes of 1377 bp (identified in 
Contig_0000353), 1272 bp (Contig_0000413) and 1593 bp (Contig_0000409) 
respectively. The gene structures of the multiple exon genes were predicted using 
FGENESH. BbiCP4 was predicted to have nine exons and an ORF size of 1743 bp 
(Contig_0000381). The ortholog of BbiCP4 in B. bovis genome (GenBank accession 
no. XM_001608666) only was predicted with seven exons and an ORF size of 1641 
bp. BbiCP4 has one more upstream exon, and the last two exons resulted from the 
division of an ancient exon, comparing with the predicted B. bovis ortholog. The 
predicted gene structure of four exons of BbiCP5 and an ORF size of 1563 bp 
(Contig_0000030) is similar to the four exons and 1626 bp of the annotated B. 
bovis ortholog (GenBank accession no. XM_001609496). 
Two annotated proteins in the T. parva genome (GenBank accession nos. 
XP_764234 and XP_764233), showed high identity respectively with the N- and C-
terminal of T. annulata SERA (TaSERA), but none of them was predicted with the 
active site cysteine residue. We used FGENESH+ with the amino acidic sequence of 
TaSERA as template to predict the structure of the SERA gene from T. parva 
(TpSERA) that contained the active cysteine residue, and used this sequence in the 
subsequent analyzes. 
In order to investigate the molecular evolution events of the families of cysteine 
protease genes from four species of piroplasma parasites, B. bigemina, B. bovis, T. 
annulata and T. parva, genome alignments were conducted using LAGAN and 
VISTA programs. We can observe that the adjacent regions to the cysteine protease 
genes are conserved (Fig. 4.1). T. annulata genome has seven CP1 paralog genes in 
tandem and disposed head to tail. In T. parva there are only six CP1 genes, and as 
the result of the difference between these two species of bovine theileriosis a gap 
in the genome alignment was observed (Fig. 4.1A).  
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Figure 4.1. VISTA identity plots between homologous regions of Piroplasmida 
species genomic DNA displaying cysteine protease genes. The gray and black 
arrows above each VISTA correspond to T. annulata annotated exon positions. The 
level of conservation (vertical axis) is displayed in the coordinates of the T. 
annulata sequence (horizontal axis). Conserved regions above the level of 
80%/100 bp (between Theileria spp.) or 40%/100 bp are highlighted under the 
curve (untranslated regions in red and codifying regions in blue). A) Identity plot 
showing cysteine protease 1 (CP1) conserved nucleotide sequences between T. 
annulata (Ta) chromosome 3 (NC_011100), T. parva (Tp) chromosome 3 
(NW_876245), B. bigemina (Bbi) Contig_0000353 and B. bovis (Bbo) chromosome 
4 (NW_001820857). B) Identity plot showing cysteine protease 2 (CP2) conserved 
nucleotide sequences between T. annulata chromosome 2 (NC_011099), T. parva 
chromosome 2 (NC_007345), B. bigemina Contig_0000413, and B. bovis 
chromosome 3 (NC_010575). C) Identity plot showing cysteine protease 3 (CP3) 
conserved nucleotide sequences between T. annulata chromosome 3 and B. 
bigemina Contig_0000409, and the absence of CP3 in B. bovis chromosome 3 (T. 
parva alignment not shown for clearness). 
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In the Babesia species studied there is only one CP1 gene with the same orientation 
as the orthologs from Theileria. There was no duplication or rearrangement events 
after speciation from a common ancestor in the case of the CP2, CP4 and CP5 gene 
families (Fig. 4.1B; results not shown for CP4 and CP5). In the CP3 gene family 
there were duplications in the Theileria species. T. annulata has two genes 
(TaCP3A and 3B) in tandem and head to tail (Fig. 4.1C), and T. parva has three 
genes disposed in the same manner (TaCP3A, TaCP3B1 and TaCP3B2). B. bigemina 
genome only has one CP3 gene, BbiCP3, aligned with TaCP3A, although we can 
observe in B. bigemina an untranslated region with moderate homology to the 
TaCP3B gene (Fig. 4.1C). 
In B. bovis there is also an untranslated region with homology to TaCP3B but there 
is no homology to TaCP3A or BbiCP3, in result from the complete deletion of the 
CP3 like gene. The deletion is in fact a substitution as the length of this region did 
not changed from T. annulata to B. bovis. But it seems that it did not resulted in a 
gene substitution as this putative untranslated region of B. bovis in a blastx search 
against the non redundant protein database at NCBI blast server gave no 
significant hits. With the deletion of the CP3 like gene, B. bovis has four Family C1 
cysteine protease genes instead of the five present in B. bigemina. 
The amino acid sequences of BbiCP1 to 5 were aligned with all known non 
redundant cysteine protease sequences from other Piroplasmids, and a 
phylogenetic tree was constructed. We can observe in the tree (Fig. 4.2) that all 
known CP sequences from Piroplasmids are separated in six main clusters, CP1 to 
CP5 and SERA. The main differences between Theileria spp. and Babesia spp. in 
cysteine proteases occurrence are the absence of the SERA representatives in 
Babesia spp. and duplications in CP1 and CP3 gene families in Theileria spp.. 
Although CP3 is absent from the B. bovis genome, it is present in B. bigemina, B. 
divergens and B. caballi. From the analysis of T. annulata and T. parva genomes 
(Fig. 4.1) we observed that gene duplications occurred in the CP1 and CP3 gene 
families, and from what we can observe in the phylogenetic tree, these duplications 
also occurred in CP1 gene family in T. equi and T. orientalis, and in CP3 gene family 
in T. cervi (Fig. 4.2). 
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Figure 4.2. Phylogenetic tree inferred from piroplasma cysteine proteases (cp) 
amino acid sequence data. Piroplasma C1 family cysteine proteases are divided in 
six main clusters that preceded speciation. Tree constructed using the Neighbor-
Joining method (Saitou and Nei, 1987), with superimposed bootstrap values 
(Felsenstein, 1985). Accession numbers are provided when available. 
Abbreviations: Bbi, B. bigemina; Bbo, B. bovis; Bc, B. caballi; Bd, B. divergens; Ta, T. 
annulata; Tc, T. cervi; Te, T. equi; To, T. orientalis; Tp, T. parva. 
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CP1 genes from Theileria spp. have in general a higher identity to their orthologs in 
other species than to their paralogs in the same genome. For example, ToCP1F 
share 62% nucleotide sequence identity with TaCP1F and TpCP1F and only 52% 
with ToCP1B1 and ToCP1B2. In the cases that the paralogs present in the same 
genome share a higher identify than with the orthologs, they were named with the 
same letter, as for TaCP1A1 and TaCPA2 that share 92% nucleotide sequence 
identity, and this suggests a recent duplication event. 
CP1 members are in general more identical and similar to papain than the other 
Family C1 cysteine proteases from Piroplasms (Table 4.1). CP1 to 3 and SERA 
groups show higher protein sequence similarity with cathepsin L-like CPs, and CP4 
and 5 groups with cathepsin C-like. 
 
Table 4.1. Protein sequence similarity and identity matrix. The percentage of 
similarity (in blue) and identity (in red) of the cysteine protease sequences was 
calculated by the MatGat v2.0 software (Campanella et al., 2003). 
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BbiCP1   27 22 19 20 35 35 26 32 34 31 32 25 23 20 17 18 17 26 
BbiCP2 42   21 19 20 30 30 22 26 26 29 28 32 21 19 14 18 14 25 
BbiCP3 40 37   18 17 24 24 19 24 21 21 21 18 29 25 16 19 13 20 
BbiCP4 34 33 36   32 20 20 18 18 20 20 20 18 19 19 32 31 14 15 
BbiCP5 36 34 36 49   18 18 17 19 18 18 19 17 20 17 21 36 18 19 
TaCP1A1 52 47 38 37 35   92 37 41 39 45 43 22 25 21 16 18 15 25 
TaCP1A2 52 47 39 37 35 95   38 43 40 44 42 24 25 21 16 17 15 25 
TaCP1B 46 40 38 34 34 54 56   32 34 35 34 20 22 18 14 18 15 21 
TaCP1C 50 44 39 35 34 60 61 50   38 37 36 24 26 21 15 17 15 24 
TaCP1D 51 46 37 35 37 60 60 52 58   41 38 26 24 20 15 17 14 26 
TaCP1E 50 47 36 36 35 63 63 54 58 62   71 27 24 21 15 18 18 25 
TaCP1F 50 48 37 33 38 64 63 53 55 60 81   27 26 20 14 19 16 26 
TaCP2 42 51 34 31 31 44 44 39 41 48 47 46   23 18 14 15 15 22 
TaCP3A 40 37 46 35 34 42 42 41 41 43 42 41 37   30 17 18 16 22 
TaCP3B 37 33 45 37 31 35 35 34 36 33 37 36 31 44   19 18 17 19 
TaCP4 30 26 29 48 36 29 29 27 30 28 28 29 26 30 31   23 17 15 
TaCP5 35 30 36 48 55 36 35 37 35 38 34 35 30 38 34 35   17 18 
TaSERA 31 29 27 28 34 30 30 30 32 28 31 30 29 33 33 30 34   15 
Papain 40 43 35 31 31 43 42 35 39 45 41 42 37 33 28 23 32 26   
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Figure 4.3. Multiple sequence alignment of the deduced amino acid sequences of 
the cathepsin L-like cysteine proteases BbiCP1 to CP3 and papain. Identities and 
similarities are shaded (75%) in dark and light grey respectively. Predicted 
transmembrane domains are boxed, amino acids representing the ERFNIN and 
GNFD prodomain motifs are labelled with asterisks, the position of the mature 
domain processing site of papain are indicated by an arrowhead, all cysteine 
residues involved in disulphide bridges are labelled by a closed circle, residues 
making up the active sitecleft (S1, and S2 subsites) are indicated accordingly, and 
catalytic amino acids are shaded in black. 
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BbiCP1 to 3 shares many features with papain, including a 20-23 amino acid 
putative trans-membrane domain, the presence of the ERFNIN and GNFD pro-
sequence motifs typical of cathepsin L-like cysteine proteases (Sigwali et al., 2001), 
conservation of catalytic residues, and six cysteine residues involved in disulphide 
bond formation in the mature protease sequence (Fig. 4.3). 
BbiCP1 to 3 have hydrophobic residues (Phe, Val and Tyr respectively) at the 
amino acid residue 205 (mature papain numbering) of the protease S2 pocket, 
typical of mammalian cathepsin L-like cysteine proteases (Sajid and McKerrow, 
2002). The amino acid residue 205 is thought to be critical to the substrate 
preference in the S2 subsite, possibly because hydrophobic residues do not 
stabilize polar residues and thus limiting access to the catalytic triad. BbiCP1 to 3 
have an unusual insert between highly conserved amino acid residues near the C-
terminus and long prodomains of 200 to 300 amino acids, typical of Apicomplexa 
cysteine proteases (Rosenthal, 2004). 
All the other cysteine proteases from Babesia and Theileria also have long 
prodomains. CP1B, CP3A and SERA from Theileria spp. have C-terminal extensions 
with a high percentage of amino acids with electrically charged side chains (Lys, 
Arg and Glu). In Babesia spp. the active site residues are conserved, but in Theileria 
spp. there are some unusual mutations (Fig. 4.4). TaCP2 and TpCP2 have a serine 
residue instead of the active site cysteine residue, also observed in some members 
of SERA family from Plasmodium falciparum (Hodder et al., 2003). TaSERA and 
TpSERA do not show this substitution and have the conserved active site cysteine 
of cysteine proteases. CP1B family have a mutation in the active site cysteine into 
aspartic acid (TaCP1B and TpCP1B) or into glycine (ToCP1B1 and B2). The 
majority of the CP1 proteins from Theileria spp. have an unusual insertion of one 
or two residues between the glutamine of the oxyanion hole and the active site 
cysteine (Fig. 4.4). 
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Figure 4.4. Sequence alignment 
spanning the active site cysteine 
(black arrow) and the predicted 
glutamine of the oxyanion hole 
(white arrow) of cysteine 
proteases (cp) from B. bigemina 
(Bbi), B. bovis (Bbo), T. annulata 
(Ta), T. parva (Tp), T. orientalis 
(To) and T. equi (Te). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.2. Recombinant expression and activity of babesipain-1 
The full length babesipain-1 gene was PCR amplified from genomic DNA. 
Babesipain-1 nucleotide sequence (GenBank accession no. FJ859910) from an 
isolate from Israel is 98% identical to the sequence of BbiCP1 that was identified in 
the B. bigemina genome database (virulent Australian isolate). The full length 
babesipain-1 gene was cloned into the expression vector pGEX-6P-1, and the 
recombinant fusion protein GST-babesipain-1 was successfully produced in a 
recombinant E. coli system (Fig. 4.5A). 
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Figure 4.5. Expression, purification and gel substrate activity of recombinant 
babesipain-1. The expression of the 75 kDa GST-babesipain-1 was evaluated by 
12.5 % (w/v) SDS-PAGE (A). Uninduced E. coli Rosetta-gami 2 cells and induced 
with IPTG for 2h. Fusion GST-babesipain-1 protein was purified by affinity 
chromatography (B): soluble fraction of induced cells, flowthrough, and eluate. The 
concentrated pool of eluates was also evaluated by gelatin zymography (C) 
showing activity. The positions of molecular weight markers are labelled in kDa. 
Black arrows indicate the GST-babesipain-1 fusion protein and white arrows 
indicate activity. 
 
 
Three E. coli strains were transformed with the pGEX-6P-BigCis1 expression 
construct, and a small scale expression experiment was conducted to compare 
expression levels, which were similar in the different strains. The liquid cultures of 
E. coli Rosetta-gamiTM 2 (RG2) transformed using TransformAidTM Bacterial 
Transformation System (Fermentas, EU) with pGEX-6P-BigCis1 had a reduced 
duplication time (i.e. toxicity) in comparison with cultures of the transformed 
strains XL1-Blue and BL21 and non transformed RG2. Commercial competent RG2 
(Novagen) were also transformed with pGEX-6P-BigCis1, but while colonies were 
visible in solid LB-Lennox medium (Lennox, 1955), growth was not observed in 
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liquid cultures. Soluble extracts of the IPTG induced cells pellet of the three strains 
transformed with the expression vector pGEX-6P-BigCis1 showed protease activity 
with the four substrates used in the assay (Fig. 4.6A). Soluble fractions of 
transformed RG2 showed an 11 to 49 fold increase in activity in comparison with 
transformed BL21 depending on the substrate. Activity was not detected in non 
transformed cells or transformed with the naked vector pGEX-6P-1. We concluded 
that the observed protease activity was from the recombinant babesipain-1, and 
probably it was responsible for the toxicity observed in transformed RG2 cultures. 
 
 
Figure 4.6. Babesipain-1 activity assays. (A) Effect of E. coli strain and substrate in 
the activity of soluble fractions from induced cells with IPTG. (B) Activity of 
fractions collected in the affinity purification. Abbreviations: RG2, Rosetta-Gami2; 
XL1, XL1Blue; SF, soluble fraction; FT, flowthrough; E, elution. 
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The majority of the recombinant GST-babesipain-1 protein was expressed in the 
insoluble form, since an increase of expression was observed in the total extract 
after induction (Fig. 4.5A) and the recombinant protein was undetectable in the 
soluble fraction (Fig. 4.5B). The soluble GST-babesipain-1 fusion protein was 
purified by affinity chromatography, but although alterations to the protocol were 
made, the elution fractions showed several proteins in a SDS-PAGE gel (Fig. 4.5B). 
We assessed the protease activity of the purification fractions (Fig. 4.6B) and 
observed that the column retained the GST-babesipain-1 fusion protein, since the 
activity of the pre-elution fraction (Eluate 0) was higher than the activity of the 
initial soluble fraction. The lower activity of the GSH elution fractions (Eluate 1 to 
6) indicates that babesipain-1 retained activity at neutral pH (1x PBS pH 7.3 used 
in the purification steps) and self processed the GST-propart prior to the elution 
steps with GSH. Self-processing of GST-babesipain-1 was confirmed by gel 
substrate activity analysis (Fig. 4.5C) that revealed activity at approximately 30 
kDa, the predicted size of the mature enzyme. The presence of two bands in the gel 
substrate indicates that self-processing was incomplete and is possibly a multi-
step process, which explains the presence of several bands in the elutions and in 
the concentrated pool of the GSH elutions (Fig. 4.5B). The two strong bands 
observed in the SDS-PAGE gel at 30 kDa and 27 kDa, present in the pool of eluates, 
corresponds to the released GST protein (confirmed by western blotting), which 
was resistant to babesipain-1 proteolytic activity. The activity of the partially 
processed and mature babesipain-1 (pool of the eluates) was completely inhibited 
by the specific inhibitors of cysteine proteases E-64 (5µM) and leupeptin (50µM). 
 
 
4.4. Discussion 
Here we report the identification in the unfinished B. bigemina genome of five 
putative genes encoding papain-like cysteine proteases of Family C1 and the 
relationship with genes from the complete and annotated genomes of several 
piroplasms. We also showed that one of the newly identified genes in the B. 
bigemina genome encodes an active cysteine protease. Babesipain-1 is a cathepsin 
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L-like cysteine protease that shares many features with papain (Fig. 4.3) and is the 
first cysteine protease from piroplasms described with proteolytic activity. 
Although cysteine proteases usually have autolysis activity at acidic pH (Brömme 
et al., 2004), babesipain-1 auto processed at neutral pH and also showed activity in 
the cultures of transformed E. coli RG2 cells. Even if E. coli RG2 cells promoted the 
correct folding of a higher amount of babesipain-1 in comparison with the other E. 
coli strains used, the majority of the recombinant protein was expressed as 
inclusion bodies. The combination of these factors greatly reduced the final yield of 
recombinant babesipain-1 obtained. Other production and/or purification 
strategies must now be developed in order to obtain sufficient amounts of 
recombinant babesipain-1 to proceed to further characterization and inhibition 
studies. Nevertheless, activity of babesipain-1 was completely inhibited by E-64, 
and the lipophilic compound but similar in action E-64d effectively inhibit in vitro 
the growth of B. bovis parasites and invasion of host erythrocytes (Okubo et al., 
2007). In B. bovis the probable candidates for E-64d inhibition are the two 
cathepsins L-like, BboCP1 and BboCP2, and possibly calpain (GenBank accession 
no. XP_001611895). CP1 (babesipain-1) of Babesia spp. is therefore a potential 
drug target of a shortlist of essential cysteine proteases. 
Genes of cysteine proteases of piroplasms were previously described (Baylis et al., 
1992; He et al., 2005; Holman et al., 2002; Nene et al., 1990; Sako et al., 1999), as 
single or multi copy genes but the relationship between them was not clear. In 
view of the results presented here, previous comparisons were not always made 
between orthologs, or even between members of the same phylogenetic group, 
principally due to the lack of information at the time of analysis. We showed that 
there are six distinct groups of cysteine protease genes of Family C1 in Theileria 
spp. and four to five groups in Babesia spp.. More than the absence of the SERA like 
protease gene group in Babesia, the overall content of cysteine protease genes 
suggests that after the separation from a common ancestor, Babesia lost cysteine 
protease genes and Theileria gained through duplication of the existent ones (13 
cathepsin L and C-like genes present in both T. annulata and T. parva against only 5 
in B. bigemina and 4 in B. bovis). All analysed species have two cathepsin C-like 
groups, and therefore the differences observed are in the number of cathepsin L-
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like groups. Molecular evolution in Theileria occurred not only in a sheer increase 
in the number of genes, but also in sequence diversity. The active sites of cysteine 
proteases of Theileria CP1 and CP2 groups have unusual mutations and insertions 
that show no parallel in Babesia (Fig. 4.4). CP1B of T. annulata and T. parva show a 
substitution in the active site cysteine into aspartic acid and, in T. orientalis, the 
apparent proteolytically inactive CP1B has the catalytic cysteine substituted into 
glycine, and show binding affinity to haemoglobin (He et al., 2005). Although it was 
suggested that this binding activity could be related to detoxification/uptake of 
haeme, a mechanism also present in other protozoan parasites like Leishmania 
donovani (Krishnamurthy et al., 2005), this could imply that Babesia developed a 
different mechanism of detoxification and/or feeding since there is only one CP1 
gene in Babesia with proteolytic activity as we showed. Most of the CP1 group 
members from Theileria spp. have an unusual insertion of one or two residues 
between the glutamine of the oxyanion hole and the active site cysteine (Fig. 4.4). 
Of the CP1 members that maintain the catalytic cysteine residue, CP1C and CP1E 
have unusual mutations of the conserved glycine23 (papain numbering) to serine 
and tyrosine respectively. In the rodent Plasmodium spp. a mutation in glycine23 to 
alanine, altered specificity and decreased activity (Singh et al., 2002). It was 
suggested that this substitution in the rodent Plasmodium spp. may confer an 
increase in specificity to necessary substrates without unwanted proteolytic 
digestion, and this also may occur in Theileria spp.. Also, in another protozoan 
parasite, Leishmania mexicana, the cathepsin L-like cpb cysteine protease genes 
found in allelic tandem arrays of 19 copies, have distinct activities reflecting the 
differences in the amino acid sequences, that suggested the authors that the 
isoenzymes codified by the individual genes of the array perform different 
functions (Mottram et al., 1997). The mutations and insertions observed between 
the glutamine of the oxyanion hole and the active site cysteine of Theileria CP1 and 
CP2 groups (Fig. 4.4) may therefore confer specificity to different substrates and 
possibly implicating different roles in the life cycle. 
The Theileria species studied have a single copy gene similar to the multigene 
SERA family from P. falciparum (PfSERA), and all are adjacent in the respective 
genomes to a HesB member protein (McCoubrie et al., 2007) that putatively 
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participates in the biosynthesis of iron-sulphur proteins. SERA family members 
possess a central domain that has homology to papain. PfSERA5 is a fairly typical 
cysteine protease except where the active site cysteine has been replaced with a 
serine (Hodder et al., 2003). A similar mutation also occurred in Theileria, but 
remarkably it occurred in the CP2 gene family. It is interesting that this unusual 
mutation occurred in different gene families and organisms. The serine-type 
PfSERA5 possess chymotrypsin-like proteolytic activity, and is thought to be 
involved in parasite egress and/or erythrocyte invasion (Hodder et al., 2003). The 
cysteine-type SERAs of Plasmodium spp. have primary roles in the pre erythrocytic 
stage and in the mosquito sexual stages (Aly and Matuschewski, 2005; Schmidt-
Christensen et al., 2008). The Theileria SERA is likely to be functionally more 
related to the cysteine-type SERA than to the serine-type SERA from Plasmodium 
spp., since it contains the catalytic cysteine, and therefore may also play a role in 
the pre erythrocytic stage. It is noteworthy that CP1B, CP3A and SERA from 
Theileria spp. have putative C-terminal extensions that may be cleaved by another 
protease, similar to the proteolytic maturation what occurs with PfSERA (Yeoh et 
al., 2007). Further studies are needed to clarify the functional role of Theileria 
SERA and its relationship with PfSERA. 
Babesia apparently lost its SERA gene maintaining an ortholog of the HesB member 
protein (GenBank accession no. XP_001611819) that in Theileria spp. and 
Plasmodium spp. is clustered next to the SERA genes (Arisue et al., 2007). In B. 
bovis genome it also occurred a recent deletion of the CP3 gene given that this gene 
is present in B. bigemina, B. caballi and B. divergens (Fig. 4.2). The biological 
significance of these deletions remains uncertain, but it is the function of the 
products of the undeleted genes in Theileria that may help us comprehend. Babesia 
do not invade lymphocytes as Theileria do, and since cysteine proteases are 
involved in invasion or egress in other parasitic protozoa (Dowse and Soldati, 
2004; Rosenthal, 2004; Sajid and McKerrow, 2002; Yeoh et al., 2007), the total 
differences observed in CPs between these genera may, in part, explain these 
rather different mechanisms of infection in the host vertebrates. 
In conclusion, although comparisons of the genomes of Babesia and Theileria 
species revealed high conservation of gene sequences and synteny (Brayton et al., 
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2007; Pain et al., 2005), in respect to cathepsin L-like cysteine proteases, there are 
significant differences between both genera. Babesia spp. have a low number of 
cathepsin L-like cysteine proteases (2 to 3 genes) in comparison with the closely 
related Theileria spp. (11 genes) and also with Plasmodium spp. (16 genes in P. 
falciparum)( Wu et al., 2003; Rosenthal, 2004). The limited and thus essential 
babesial cathepsin L-like cysteine proteases maintain their importance as potential 
drug targets. 
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5.1. Introduction 
Babesiosis has long been recognized as an economically significant disease of 
cattle (Bock et al., 2004). Live vaccines are the main measure to control bovine 
babesiosis in many regions of the world, but breakdowns of protective immunity 
are common as the vaccines do not offer cross protection against the several local 
existing variants (de Waal and Combrink, 2006; Fish et al., 2008). 
Chemoprophylaxis is also used as a method of short-term protection, during 
outbreaks, and other temporary circumstances, as when pregnant cows are at 
increased risk of transmission and consequent abortion or when animals are 
momentarily relocated (Bock et al., 2004; de Waal and Combrink, 2006). Extensive 
outbreaks of the disease also occur in herds of susceptible unvaccinated cattle 
transported to natural endemic stable areas (Alfredo et al., 2005; Bock et al., 2004). 
However, control of babesiosis currently requires more specific, fast acting, 
reliable and safer chemotherapeutic treatments (Vial and Gorenflot, 2006). Thus, 
the identification and characterization of new drug targets for chemotherapy is a 
pressing priority. 
The members of the Clan CA, or papain-family of cysteine proteases are the most 
common proteases in protozoan parasites and are essential to the life cycle and 
pathogenicity of these organisms (Sajid and McKerrow, 2002). Hence, cysteine 
proteases of protozoan parasites are recognized drug targets and specific 
inhibitors are in validation for chemotherapy of leishmaniasis, malaria, and 
trypanosomiasis (McKerrow et al., 2008). In Babesia bovis, another agent of bovine 
babesiosis, essential roles for cysteine proteases were suggested when it was 
demonstrated that cultured parasites showed reduced growth when incubated 
with the cell permeable cysteine protease inhibitors ALLN and E-64d (Okubo et al., 
2007). Cysteine proteases of Babesia spp. may therefore be suitable as new 
chemotherapeutic targets. Three cathepsin L-like cysteine proteases, named 
babesipains, were already identified in the B. bigemina genome (Chapter 4). 
Babesipain-1 was cloned, expressed as a fusion protein with gluthatione S-
transferase (GST) and the soluble protein purified by affinity chromatography. The 
recombinant babesipain-1 had activity against typical peptide substrates of 
cysteine proteases, and was inhibited by E-64, but the low yield of the soluble 
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purification prevented additional characterization (Chapter 4). In this chapter, we 
report the improved production of babesipain-1 by purification of the insoluble 
recombinant form, refolding of the denatured protein and the biochemical 
characterization of this potential drug target. 
 
 
5.2. Materials and methods 
5.2.1. Materials 
The inhibitors 4-(2-Aminoethyl) benzenesulfonyl fluoride (AEBSF), 3,4-
dichloroisocoumarin (DCI), ethylenediaminetetraacetic acid (EDTA), 
phenylmethylsulfonyl fluoride (PMSF), egg cystatin, 1,10-phenanthroline, N-acetyl-
L-leucyl-L-leucyl-L-argininal (leupeptin), pepstatin-A, N-(trans-epoxysuccinyl)-l-
leucine 4 guanidinobutylamide (E-64), and N-acetyl-leucineleucine-norleucinal 
(ALLN) were obtained from Sigma. 
 
5.2.2. Expression and purification of recombinant babesipain-1 
The babesipain-1 gene was previously amplified with primers containing appropriate 
restriction sites and cloned (Chapter 4). Full-length babesipain-1 was released from 
pTZ57R-BigCis1 by digestion with SmaI and XhoI and subcloned into pGEX-6P-1 
expression vector (GE Healthcare, Buckinghamshire UK) digested with the same 
enzymes. The pGEX-6P-BigCis1 construct was transformed using the TransformAid
TM
 
Bacterial Transformation System (Fermentas, EU) into E. coli BL21 cells (GE 
Healthcare, Buckinghamshire UK), and cultures were induced at an Abs 600nm of 1.0 
for 3h with 1mM isopropyl-β-D-thiogalactopyranoside (IPTG). 
The induced cell pellet from 1 L of culture was collected, resuspended with 30 mL of 
100 mM Tris pH 8.0, 0.2 % (v/v) Triton X-100, and lysis was performed by sonication. 
Lysed cells were diluted to 250 mL in Urea Wash Buffer (100 mM Tris pH 8.0, 0.2 % 
(v/v) Triton X-100, 500 mM Urea) and stirred for 30 min at room temperature. 
Insoluble material containing the recombinant protein was pelleted by centrifugation at 
27,000 × g for 10 min. The pellet was resuspended with 250 mL Urea Wash Buffer, 
stirred and pelleted in the same previous conditions. This procedure was repeated 3 
more times. The washed pellet was then resuspended in 40 mL solubilization buffer (8 
M Urea, 100 mM Tris pH 8.5, 32 mM β-mercaptoethanol) and stirred overnight at 4 ºC 
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to solubilise the recombinant material. Residual insoluble material was removed by 
centrifugation at 27,000 × g for 30 min. 
 
5.2.3. Refolding of recombinant babesipain-1 
Refolding of the recombinant babesipain-1 was optimized by testing more than 100 
different buffer combinations in a microplate format as described previously (Sijwali et 
al., 2001a). Buffers differed in pH, the concentration of redox couple (reduced 
glutathione (GSH) to oxidized glutathione (GSSG)), aggregation suppressors (L-
arginine, KCl, Triton X-100, and polyethylene glycol), and co-solvents (glycerol and 
sucrose). Refolding was initiated by 100-fold rapid dilution (Hirose et al., 1989) of ice-
cold reduced–denatured protein to a final protein concentration of 0.1 mg/mL in 300 µl 
of ice-cold refolding buffer followed by incubation at 4 ºC for 16 h. Refolding 
efficiency was evaluated by assaying 50 µl of each refolding reaction for hydrolysis of 
Z-Phe-Arg-AMC as described below (with modification in pH to 5.0), and the 
efficiency for each reaction was defined as the percentage of the maximum difference of 
hydrolysis achieved in this experiment. For large-scale refolding, recombinant 
babesipain-1 was rapidly diluted 100-fold in 2 litres of ice-cold optimized refolding 
buffer (20 mM Tris pH 11, 1 mM EDTA, 5 mM GSH, 0.5 mM GSSG) and incubated at 
4 ºC for 16 h. The resulting soluble matter was concentrated 10 times using an Amicon 
stirred cell (Millipore, Watford, UK) fitted with a 10 kDa cut-off membrane. To allow 
processing to an active enzyme, the concentrated preparation was acidified by the 
addition of one-tenth volume of 1 M sodium acetate buffer pH 4.6 (final pH 5.0) and the 
sample was incubated at 4 ºC for 20 h. Insoluble material was removed by 
centrifugation at 27,000 × g for 30 min. The resulting soluble protein was then further 
concentrated 8 times using an Amicon stirred cell fitted with a 10 kDa cut-off 
membrane and was stored in 50 % (v/v) glycerol at −20 ºC. 
 
5.2.4. Activity assays 
Babesipain-1 activity was assayed fluorimetrically as the hydrolysis of the substrates Z-
Phe-Arg-AMC (Sigma-Aldrich, St. Louis USA), Z-Leu-Arg-AMC, Z-Leu-Leu-Arg-
AMC and Z-Val-Val-Arg-AMC (Bachem Holding AG, Bubendorf Switzerland) was 
followed over time. 8 μL of enzyme solution was added to 100 mM sodium acetate pH 
5.5 containing 50 μM fluorogenic substrate and 1 mM DTT in a final volume of 0.2 mL 
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(or with changes in pH or reductant as described), and the release of 7-amino-4-methyl 
coumarin (AMC) was monitored (excitation 360 nm, emission 460 nm) for 30 min to 1 
h at 37 ºC with a Fluorescence Microplate Reader FLx800 (BioTek Instruments Inc., 
USA). 
For gelatin zymography, samples were mixed with SDS-PAGE sample buffer 
lacking a reducing agent, incubated 5 min at 25 °C and separated in a 12.5% (w/v) 
SDS-PAGE polyacrylamide gel, co-polymerized with 0.1% (w/v) gelatin (Heussen 
and Dowdle, 1980). The gel was washed twice with 2.5% (v/v) Triton X-100 to 
remove SDS for 30 min at 25 °C (Liotta and Stetler-Stevenson, 1990). Gel was then 
incubated overnight at 37 °C in 100 mM sodium acetate (pH 5.5), 1 mM DTT, 
before staining with Coomassie Brilliant Blue R250. The activity band was 
observed as a clear colourless area depleted of gelatin in the gel against the blue 
background. 
 
5.2.5. Enzyme Kinetics 
Babesipain-1 enzyme concentration was determined by titration with E-64 
(Barrett and Kirschke, 1981). Rates of hydrolysis of fluorogenic peptide substrates 
were determined in the presence of constant babesipain-1 enzyme concentration 
(5.13 nM). The kinetic constants Km and kcat were determined using the GraphPad 
Prism 5.0 program (GraphPad Software, San Diego California USA). The derived 
kinetic constants Km and kcat always had estimated errors of <15%. 
 
 
5.3. Results 
The full length babesipain-1 gene was previously cloned and expressed as a fusion 
protein with GST, and the expressed soluble fusion protein was purified by affinity 
chromatography (Chapter 4). This procedure yielded very low quantities of active 
enzyme for biochemical characterization. Using the same expression construction, 
we decided to proceed with the purification and refolding of the insoluble form of 
the recombinant GST-babesipain-1, which constituted the bulk of the expressed 
fusion protein. Insoluble inclusion bodies were washed with a urea buffer and later 
solubilised with 8M Urea (Fig. 5.1A). Afterwards, the denatured and reduced GST-
babesipain-1 protein was refolded in more than 100 buffer testing conditions in a 
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microplate format. Aggregation suppressors (L-arginine, KCl, Triton X-100, and 
polyethylene glycol), and co-solvents (glycerol and sucrose) did not influenced 
positively the refolding. The best tested conditions for the refolding of denatured 
babesipain-1 to an active enzyme were obtained with basic pH and a GSH:GSSG 
ratio of 5:1 or 5:0.5 (Table 5.1). The refolded protein samples showed a near to 
exponential increase in activity assays during the initial time period of analysis, 
suggesting that upon acidification to pH 5.0, the refolded pro-enzyme processed 
itself into a mature and more active enzyme. 
 
 
Table 5.1. Optimization of refolding of babesipain-1. Effect of pH and GSH:GSSG 
ratio (concentrations in mM) on the efficiency of the refolding of babesipain-1 in 
20 mM Tris. Activity of the hydrolysis of Z-Phe-Arg-AMC for each reaction were 
normalized against a maximum of 100 to express refolding efficiency. 
pH 7.5 8.0 8.5 9.0 9.5 10.0 10.5 11.0 11.5 12.0 
GSH:GSSG (Activity, % of maximum) 
10:1 0.0 0.3 35.7 56.5 68.3 90.5 83.2 92.3 83.3 89.7 
10:0.5 0.3 0.8 44.8 64.9 74.3 89.6 88.1 98.0 87.5 97.3 
5:1 0.1 24.4 54.6 72.5 77.8 91.6 84.1 94.8 89.4 98.6 
5:0.5 0.2 30.4 62.7 72.0 86.0 96.7 96.8 100.0 99.0 99.5 
2.5:0.5 0.9 31.6 51.5 61.3 72.7 80.1 77.2 87.0 76.7 85.3 
1:0.5 3.6 18.7 31.7 39.2 45.8 51.1 49.1 54.7 53.5 57.2 
0.5:0.5 2.8 11.6 20.8 25.6 30.5 32.9 34.1 39.1 37.0 39.9 
0:0 1.1 3.1 6.1 9.4 13.9 17.5 19.5 20.7 20.3 28.2 
 
 
Large-scale refolding of babesipain-1 was carried out by 100-fold rapid dilution of 
the denatured protein in optimized buffer (20 mM Tris, 1 mM EDTA, 5 mM GSH 
and 0.5 mM GSSG, pH 11.0). The profile of the refolded protein material did not 
suffered significant alterations in comparison with the denatured proteins as 
observed by SDS-PAGE analysis (Fig. 5.1). 
 
Characterization of the potential drug target cysteine protease babesipain-1 
76 
 
 
Figure 5.1. Expression, purification and gel substrate activity of recombinant 
babesipain-1. The expression of the 75 kDa GST-babesipain-1 was evaluated by 
12.5 % (w/v) SDS-PAGE (A). Uninduced E. coli BL21 cells and induced with IPTG 
for 3h. Inclusion bodies containing the denatured fusion GST-babesipain-1 protein 
were purified by Urea washes and later solubilised with 8M Urea. GST-babesipain-
1 was refolded, and later acidified to a processed babesipain-1 mixture with GST, 
and the babesipain-1 mixture with GST was then stored in 50% (v/v) glycerol. 
Activity was evaluated by gelatin zymography (B) in a one month old refolding 
sample at pH 9.0 and in 50% glycerol babesipain-1. The positions of molecular 
weight markers are labelled in kDa. Black arrow indicates the GST-babesipain-1 
fusion protein and white arrows indicate activity. 
 
The refolded pro-enzyme was then acidified to promote auto-activation. The 
conditions for the auto-activation of babesipain-1 were optimized in respect to pH 
(4.0 to 6.0) and temperature (4 °C to 37 °C). The best pH and temperature was 
defined as the condition at which the maximum of activity in the acidified samples 
was obtained after 2h and 4h of incubation. The best pH and temperature for auto-
activation were 5.0 and 4 °C. Low temperatures are routinely used to prevent 
agglomeration. Despite this, and at all temperatures, a significant amount of 
refolded protein precipitated almost immediately after change in pH, and at lower 
values than the optimum pH 5.0, the precipitated material increased significantly. 
Part of the precipitated material is composed by E. coli contaminating proteins, as 
these are not observed in SDS-PAGE analysis after acidification (Fig. 5.1A). Upon 
acidification, a change in the mobility of the 75 kDa GST-babesipain-1 was 
observed in the SDS-PAGE analysis (Fig. 5.1A). The auto-activation was confirmed 
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by gelatinase activity gel, as activity was observed as a colourless band at 
approximately 30 kDa, the estimated molecular weight of the mature babesipan-1. 
The auto-activation of babesipain-1 is a multi-step process, as an intermediate 
product with gelatinase activity at 43 kDa was observed in an old refolding sample 
(Fig. 5.1B), in which the process of maturation occurred slowly, since the storage 
conditions of pH 9.0 and 4 °C were not the most favourable. The majority of the 
protein observed at 27 kDa (Fig. 5.1A) was later confirmed as being the GST as it 
was removed by affinity purification. Although the removal of GST did not alter the 
activity of the mature babesipain-1, it changed the stability as observed as a rapid 
loss of enzyme activity in assays with the peptide Z-Phe-Arg-AMC. Cysteine 
proteases are usually relatively unstable enzymes which are prone to autocatalytic 
degradation, oxidation, and protein denaturation (Brömme et al., 2004). The more 
stable protein mixture of GST and mature babesipain-1 (active enzyme 5.6% of 
total protein) was then used in all subsequent kinetic experiments. 
Babesipain-1 had typical properties of a papain-family cysteine protease, with 
acidic pH optimum and requirement for a reducing environment for maximum 
activity (Fig. 5.2A and B). Babesipain-1 showed a broad activity spectrum under 
the pH conditions used, with more than 30% of maximum activity from pH 4.0 to 
pH 9.0. 
The interaction of babesipain-1 with inhibitors of cysteine proteases and other 
classes was also analysed (Fig. 5.2C). As is typical of cysteine proteases, 
babesipain-1 was potently inhibited by E-64, ALLN, leupeptin and cystatin. 
Inhibitors of other classes of proteases only had a minor effect or no effect. 
The ability of the mature form of babesipain-1 to cleave a variety of peptide 
substrates was examined (Table 5.2). Babesipain-1 preferred substrates with 
Valine at the P2 position with a P2 rank order of Val > Leu > Phe in contrast with 
falcipain-2 and -3 from P. falciparum that preferred Leu > Phe > Val (Sigwali et al., 
2001). The higher specificity constant (kcat/Km) for the substrate with Valine at the 
P2 position was a result of increased substrate turnover (kcat), as babesipain-1 
showed apparent higher affinity (lower Km) for the interaction with substrates 
with Leucine at the P2 position. 
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Figure 5.2. Effect of pH, reductant concentration, and inhibitors on the activity of 
babesipain-1. The activity of recombinant babesipain-1 was assayed against 50 µM 
Z-Phe-Arg-AMC in 100 mM sodium chloroacetate (pH 3.0), sodium acetate (pH 
3.5–5.5), sodium phosphate (pH 6.0–7.0) or Tris (7.5–9.0) and 1 mM DTT (A) and 
in 100 mM sodium acetate pH 5.5, with different concentrations of DTT (B). For 
inhibitor assays, recombinant babesipain-1 was added to 50 µM Z-Phe-Arg-AMC in 
100 mM sodium acetate pH 5.5, in the absence or presence of E-64 (1 µM), ALLN 
(100 µM), leupeptin (100 µM), cystatin (10 µg/mL), DCI (50 µM), PMSF (1 mM), 
AEBSF (1 mM), pepstatin (8 µM), EDTA (1 mM), 1,10-phenanthroline (0.5 mM) or 
DMSO 1 % (v/v) (C). Release of AMC was continuously monitored for 30 min, 
slopes of fluorescence over time were calculated, and results were expressed as 
percentage of maximum activity for each assay. 
 
Table 5.2. Kinetic parameters for substrate hydrolysis by recombinant babesipain-
1. 
Substrate Km  (µM) kcat  (s-1) kcat/Km  (s-1 M-1) 
Z-Phe-Arg-AMC 59.0 0.306 5.19 × 103 
Z-Leu-Arg-AMC 14.6 0.333 2.27 × 104 
Z-Leu-Leu-Arg-AMC 10.4 0.245 2.37 × 104 
Z-Val-Val-Arg -AMC 22.7 0.681 3.00 × 104 
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5.4. Discussion 
We have characterized for the first time the recombinant babesipain-1, after 
successfully improved the production of active recombinant babesipain-1 using a 
different approach in relation to a previous study (Chapter 4). Babesipain-1 had 
typical properties of a papain-family cysteine protease, including hydrolysis of 
typical papain-family peptide substrates (Table 5.2), an acidic pH optimum, 
requirement for a reducing environment for maximum activity, and inhibition by 
standard cysteine protease inhibitors (Fig. 5.2). Two potent inhibitors of 
babesipain-1, E-64d and ALLN, were also found to effectively inhibit the in vitro 
growth of B. bovis (Okubo et al., 2007). Invasion of erythrocytes by B. bovis was 
only inhibited by E-64d and not ALLN (Okubo et al., 2007), suggesting that another 
cysteine protease may be involved in this role. In the related Apicomplexan 
parasite, P. falciparum, the cysteine proteases falcipain-2 and -3 have been 
implicated in essential roles as host haemoglobin degradation (Sijwali et al., 
2001b), and rupture of infected erythrocytes (Dua et al., 2001; Hanspal et al., 
2002). Intracellular processing of these falcipains was inhibited by E-64d and 
ALLN (Dahl and Rosenthal, 2005). Accordingly, it is possible that babesipain-1 may 
digest host proteins for metabolism or participate in the rupture of erythrocytes. 
Although, pseudo food vacuoles are formed by enclosing host cytoplasm, 
intraerythrocytic Babesia spp. do not have haemozoin, the breakdown product of 
haemoglobin digestion (Kawai et al. 1999a), in contrast with Plasmodium spp. that 
use haemoglobin as a major source of nutrients and have haemozoin (malaria 
pigment) (Francis et al., 1997). In addition, Babesia spp. induce severe 
ultrastructural changes in the erythrocyte membrane and shape, with tubular 
structures extending from the surface of the infected erythrocyte membrane 
directly to the parasites, and it was suggested that Babesia spp. come into direct 
contact with the host plasma and may obtain nutrients from both outside and 
inside host cells (Braga et al., 2006; Kawai et al., 1999a; Kawai et al., 1999b). It is 
still unclear the feeding mechanisms of Babesia spp. and if it involves cysteine 
proteases. The availability of recombinant cysteine proteases may aid in clarifying 
this subject. 
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At slightly basic pH 7.5, falcipain-2 with around 40% of maximum activity is more 
active against peptide substrates than falcipain-3 with only 5% (Sijwali et al., 
2001b). Accordingly, falcipain-2 cleaves cytoskeletal proteins (pH optimum of 7.5 
to 8.0) and may facilitate erythrocyte rupture by mature schizonts (Dua et al., 
2001; Hanspal et al., 2002). Babesipain-1 also had considerable activity against a 
peptide substrate at slightly basic pH 7.5 (>80% maximum activity), although it 
remains uncertain if this is the result of an adaptation to the absence of an acidic 
environment as the plasmodial food vacuole, or if babesipain-1 participates in 
degradation of host proteins in the cytosol where a slightly basic optimum pH 
would be ideal. 
The nature of the S2 pocket and in particular the residue present in the hollow end 
of the pocket is essential to the substrate specificity of clan CA enzymes. The S2 
pocket is usually constituted by hydrophobic residues, but the key residue (residue 
205 in papain) present at the bottom is not conserved (Sajid and McKerrow, 2002). 
Falcipain-2 and -3 have in this critical position the polar residues Asp234 and 
Glu243, respectively (Kerr et al., 2009). Babesipain-1 has a bulky hydrophobic 
phenylalanine in the end of the S2 pocket, an unusual feature in common with the 
human cathepsin W and with the CP1 protease from the cellular slime mold 
Dictyostelium discoideum (Brinkworth et al., 2000). Babesipain-1 showed a P2 rank 
order of Val > Leu > Phe in contrast with falcipain-2 and -3 that preferred Leu > 
Phe > Val (Sigwali et al., 2001). The preference of babesipain-1 for the small 
residue valine, suggests a narrow S2 Pocket and therefore restricted substrate 
specificity, although the overall environment is of great importance and not only 
the nature of the end of the S2 pocket. 
In light of recent work on the inhibition of cultures of B. bovis parasites (Okubo et 
al., 2007) suggesting babesipain-1 as a potential drug target, the availability of this 
recombinant protein can facilitate research in this area. 
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6.1. Discussion 
Bovine babesiosis is a tick–borne disease with significant morbidity and mortality, 
that impose severe restrictions to cattle movement, and the economic losses 
associated to this disease can be considerable (Wright, 1990). Control measures of 
bovine babesiosis include the eradication or reduction of ticks, diagnosis, 
vaccination and treatment. The increasing resistance of ticks to acaricides 
constitutes a current and serious problem in the management of tick control (Graf 
et al., 2004). Moreover, live attenuated vaccines are used for the control of 
babesiosis in many parts of the world, but rely on region-specific attenuated 
strains for which vaccine breakthrough is not uncommon (de Waal and Combrink, 
2006). Outbreaks also occur in endemic areas especially after cattle movements 
and consequent challenge with different strains (Alfredo et al., 2005; Bock et al., 
2004). Therefore, control of babesiosis relies in the prompt diagnosis and effective 
treatment as the last alternative. Detection of infections for epidemiologic 
purposes is also important to evaluate the effectiveness of adopted control 
measures. This work was designed to contribute to the improvement of some of 
the control measures, and the objectives of this study include: the development of 
a new molecular diagnostic method (Chapter 2), survey on the status of babesiosis 
in Mozambique (Chapter 2 and 3), identification of proteases as potential drug 
targets (Chapter 4), and biochemical characterization of a cysteine protease as a 
new drug target (Chapter 5). This work also had the objective to increase the 
scientific cooperation between Mozambique and Portugal in this important 
veterinary area. This study has two apparently distinct sections, in diagnosis and 
treatment areas, but the two areas are closely related, since treatment begins with 
proper diagnosis, and epidemiological data is fundamental to access the proper 
treatment. In an endemic region, the treatment should allow the development of 
immunity, and in other scenarios, like the US free zone from bovine babesiosis, the 
treatment should result in the complete clearance of the parasites. In the first 
section of this study, two molecular detection methods were compared with a new 
method developed in this work, and the status of bovine babesiosis was evaluated 
using these methods. And, in the second section, particular interest was given to 
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the identification and characterization of cysteine proteases that are already drug 
targets for other protozoan parasites.  
 
6.1.1. Development of a new molecular diagnostic method 
Diagnosis of clinical cases of babesiosis in Mozambique was commonly based in 
the classical method of examination of Giemsa stained blood smears from 
suspected animals. The development of PCR based techniques, lead to new and 
more sensitive diagnostic methods. Although the molecular diagnostic methods 
require more instrumentation, they allow for proper identification and 
classification of pathogens often present with different but morphological similar 
parasites and in low parasitaemias (Bӧse et al. 1995). Several methods have been 
described for detection and differentiation of bovine babesiosis infections 
including the nested PCR (Figueroa et al., 1993), reverse line blot (RLB) 
hybridization (Gubbels et al., 1999), LAMP (Iseki et al., 2007) and real time PCR 
(Buling et al., 2007). 
In recent years the RLB assay, a molecular based technique that allows the 
simultaneous detection of several haemoparasites, was implemented in 
Mozambique (Faculty of Veterinary, Eduardo Mondlane University). Nonetheless, 
in contrast to what was previously assumed, and although B. bovis infections were 
detected, B. bigemina infections were not detected by the RLB assay in previous 
studies and in the initial assays conducted in this project (Chapter 3). It became 
therefore necessary to use another method or to develop a new one. Both 
strategies were followed at the same time in order to successfully detect B. 
bigemina natural infections in Mozambique. In Chapter 2, the development of a 
new molecular diagnostic method for the detection of B. bigemina and B. bovis in 
field samples is described. 
Primers were chosen for the new method based on the babesial aspartic protease 
single copy gene present in both genomes of B. bigemina and B. bovis. Primers were 
designed to have a high temperature of melting (Tm), approximately 30 bp long, 
and 40 to 60% GC content, in order to allow the use of an annealing temperature 
that is several degrees higher than the Tm of the primers. Although primer 
annealing and amplification is less efficient at this higher temperature, it is much 
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more specific (Hecker and Roux, 1996). And to further increase the specificity of 
the PCR we used a hot-start polymerase, to minimize the yield of non-specific 
products and the formation of the so-called primer dimer (Kermekchiev et al., 
2003). 
The new seminested hot-start PCR method was assayed in parallel with the nested 
PCR described by Figueroa et al. (1993). Both methods allowed the detection of B. 
bigemina and B. bovis in high frequency in random field samples from one farm 
located in Maputo province, Mozambique. However, the seminested hot-start 
method was comparatively more sensitive: allowed detection in the first PCR in 
opposition to the old method that only permitted detection in the second or nested 
PCR; and, the new method was more specific in the amplification of B. bigemina 
amplicons than the old method. The combination of long primers and a hot-start 
polymerase were determinant to the improvement of the specificity of the PCR and 
consequently to the improvement of the sensitivity of the method. This strategy 
can be used in the development of other molecular detection methods for the 
detection of other pathogens, or in the improvement of previous methodologies. 
The new method requires validation for use in other regions of the world that may 
have local strains with sequence differences in the primers regions, although in the 
development of the method, amplifications from genomic DNA of Israeli strains of 
B. bigemina and B. bovis were positive. 
The LAMP assay (Iseki et al., 2007) and the real time PCR (Buling et al., 2007) were 
not used in this study since they were published after the initial development of 
the seminested hot-start PCR. These methods also require specific reagents and/or 
proper apparatus, not available in Mozambique where the method is to be 
implemented. 
The seminested hot-start PCR method was then used to study the status of bovine 
babesiosis in different geographical locations of Maputo province as described in 
Chapter 3. 
 
6.1.2. Survey on the status of babesiosis in Mozambique 
The study on bovine babesiosis in Mozambique was extended with the collection of 
blood samples in other 4 farms geographically well distributed through Maputo 
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province. In total, 477 samples from 5 farms were analyzed by two different 
methods, the seminested hot-start PCR and the RLB assay, with the objective to 
evaluate the prevalence and distribution of bovine babesiosis and of other 
haemoparasites. 
The detection results differed considerably between both methods and locations. 
Using the seminested hot-start PCR, detection of B. bigemina between farms varied 
from 30% to 89% with an overall detection of 61%, and detection of B. bovis 
ranged between 27% and 83% with an overall frequency of 53%. Using the RLB 
assay, B. bigemina was not detected and detection of B. bovis ranged between 0% 
and 17% with a total frequency of 5.1%. 
Analysis of new sequences of the 18S rRNA gene from B. bigemina obtained in this 
study, revealed that the current B. bigemina RLB probe is unspecific for the 
identification of all the identified isolates from Mozambique, as was also recently 
reported for Argentinean isolates (Petrigh et al., 2008). This clearly explains the 
0% detection of B. bigemina by the RLB. Nevertheless, the detection of B. bovis by 
the RLB (17%) was also below the detection results by the seminested hot-start 
PCR (53%). This difference may result from the probe for B. bovis being unspecific 
to all the isolates or lower sensitivity of the RLB due to PCR competition when 
using complex field samples. Similar low detection results using the RLB assay 
were obtained by Oura et al. (2004) in a survey conducted in Uganda, where B. 
bigemina was detected in 2% of random field samples and B. bovis was not 
detected. 
Although the RLB assay was less sensitive in the detection of bovine babesiosis, it 
allowed the detection in the region of Maputo province of ten different species of 
the four genera Babesia, Theileria, Anaplasma and Ehrlichia. Overall, eleven 
parasite species were detected by the methods used, and the results show that 
multiple infections with several species of cattle haemoparasites are common in 
Maputo province. 
The sequences of the 18S rRNA genes cloned in this study also showed that there is 
microheterogeneity, where minor nucleotide sequence differences occur in 
homologous regions of the gene (Chae et al., 1999), in this highly conserved gene 
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between isolates of the same species of Babesia or Theileria, indicating the high 
variability within the species in the field. 
The variability within species and the presence of common multiple infections that 
this study showed adds to the presence of several vectors and game reservoirs, 
and a greater range of susceptibility of bovine breeds, in the complex scenario of 
host, vector and bovine babesiosis interactions in Mozambique. Accordingly, 
detection of bovine babesiosis varied greatly between locations. If the higher 
prevalence in Umbelúzi may be explained by the presence of a susceptible breed in 
comparison with the remaining locations that have resistant African breeds, the 
results obtained in the remaining farms may be harder to elucidate. A combination 
of several factors as different microclimates, disease management, cross treatment 
with other diseases management (in Bela Vista with trypanosomiasis), and tick 
species distribution have influence and contribute for the complexity of the 
management of this disease in Mozambique. 
One approach to the control of babesiosis and other TBD rely on the development 
of endemic stability, where the majority of the cattle population is immune to the 
disease due to early natural exposure and the development of innate immunity 
(Mahoney, 1974). The results of this study show that bovine babesiosis is endemic 
in the Maputo province, although there are some locations with low prevalence 
numbers that may indicate endemic instability. Cattle owners may opt for 
intensive tick control, attempting to break the transmission cycle completely. This 
is much more costly than vaccination, and is problematic if tick control breaks 
down. In endemic unstable situations, a dry season or intensive tick control can 
result in drastic reduction of ticks and reduction of transmission to levels at which 
the disease is not maintained, to create a generation of susceptible cattle that may 
result in catastrophic outbreaks when are later challenged (Alfredo et al., 2005; 
Bock et al., 2004). The integration of strategic use of acaricides, the application of 
vaccines in endemically unstable conditions and the use of tick resistant breeds 
may in the long term achieve an effective endemic stability (Alfredo et al., 2005), 
and the availability of a sensitive detection method to access the implementation of 
these measures is of great importance. 
General Discussion and Conclusions 
88 
 
The seminested hot-start PCR was comparatively more sensitive to the RLB assay 
(Chapter 3) and to the nested PCR (Chapter 2), using random field samples from 
Mozambique. The seminested hot-start PCR is therefore the more suitable method 
of the ones tested to use in the future studies on bovine babesiosis in this country. 
 
6.1.3. Identification of proteases as potential drug targets 
Proteases found in viruses, bacteria, and parasites, are recognized as one of the 
largest potential drug target enzyme families, due to their lower homology to their 
mammalian orthologs, and offer target opportunities to identify selective 
inhibitors that have minimal cross-reactivity with host proteases (McKerrow et al., 
2008). 
In chapter 4, the data-mining of the genome of B. bigemina for the identification of 
proteases as potential drug targets is described. The focus was on the cysteine 
class of proteases that are known to be essential to the life cycle and pathogenicity 
of parasitic protozoa (Sajid and McKerrow, 2002). Cysteine proteases have 
numerous roles in Apicomplexa parasites such as catabolic functions, 
immunoevasion, enzyme activation, cellular invasion and rupture (Rosenthal, 
2004; Dowse and Soldati, 2004). Hence, cysteine proteases of protozoan parasites 
are recognized drug targets and specific inhibitors are in validation for 
chemotherapy of leishmaniasis, malaria, and trypanosomiasis (McKerrow et al., 
2008). 
Five genes were identified by sequence similarity search to be homologous to the 
cysteine protease family in the ongoing B. bigemina genome sequencing project 
database and were compared with the annotated genes from the complete bovine 
piroplasms genomes of B. bovis, Theileria annulata, and T. parva. Multiple genome 
alignments and sequence analysis were used to evaluate the molecular evolution 
events that occurred in the C1 family of cysteine proteases in these piroplasms of 
veterinary importance. 
Analysis and comparisons between the genomes of bovine piroplasms revealed 
that there are five distinct groups of cysteine protease genes of Family C1 in B. 
bigemina, four groups in B. bovis and six groups in Theileria spp.. All analysed 
species have two cathepsin C-like groups, and therefore the differences observed 
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are in the number of cathepsin L-like groups. The overall content of cysteine 
protease genes suggests that after the separation from a common ancestor, Babesia 
lost cysteine protease genes (deletion of the SERA gene, also present in 
Plasmodium spp.) and Theileria gained through duplication of the existent ones (13 
cathepsin L and C-like genes present in both T. annulata and T. parva against only 
5 in B. bigemina and 4 in B. bovis). Molecular evolution in Theileria occurred not 
only in a sheer increase in the number of genes, but also in sequence diversity. 
The active sites of the cathepsin L-like cysteine proteases of Theileria have unusual 
mutations and insertions that show no parallelism in Babesia orthologs that have 
conserved catalytic residues and hydrophobic residues in the S2 pocket 
responsible for the substrate preference to hydrophobic residues in the S2 subsite, 
characteristic of mammalian cathepsin L-like cysteine proteases. 
The total differences in number and sequence diversity observed in the cathepsin 
L-like cysteine proteases of these Genera may in part explain the rather different 
mechanisms of infection in the host vertebrates. B. bigemina and B. bovis have a 
low number of cathepsin L-like cysteine proteases (3 and 2 genes respectively) in 
comparison with the closely related Theileria spp. (11 genes) and also with 
Plasmodium spp. (16 genes in P. falciparum)(Wu et al., 2003; Rosenthal, 2004). 
Babesia parasites do not invade lymphocytes in opposition to Theileria parasites 
that have to invade first the lymphocytes in the vertebrate host, and interestingly 
Plasmodium parasites also invade hepatocytes before invading erythrocytes. In 
result of this, Theileria and Plasmodium need to invade and promote rupture of 
more types of cells in comparison to Babesia, and consequently have more and 
different substrate targets that require different and specific enzymatic activities. 
Since cysteine proteases are involved in invasion or egress in other parasitic 
protozoa including Plasmodium spp. (Dowse and Soldati, 2004; Rosenthal, 2004; 
Sajid and McKerrow, 2002; Yeoh et al., 2007) the divergent cysteine proteases of 
Theileria probably have roles in the invasion or egress in the lymphocyte stage, 
and this may explain the observed evolution through duplication and diversity of 
these enzymes. 
One of the three cathepsin L-like enzymes of B. bigemina, babesipain-1, was 
expressed in a recombinant expression system, and for the first time the activity of 
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a cysteine protease from piroplasms was described. The activity of babesipain-1 
was completely inhibited by E-64, and therefore, babesipain-1 is one of the 
possible targets of the inhibitor E-64d that effectively inhibited in vitro the growth 
of B. bovis parasites and invasion of host erythrocytes (Okubo et al., 2007), and 
indicated that cysteine proteases are essential to the life cycle of Babesia. The 
reduced number of cathepsin L-like cysteine proteases from Babesia decreases the 
possibilities of occurrence of functional redundancy, where different enzymes have 
similar importance in a specific role, and increases the probability of development 
of inhibitors that block an essential role and thus prevents the development of 
resistance. Therefore, babesipain-1 and the other two babesial cathepsin L-like 
cysteine proteases retain their importance as potential drug targets. 
 
6.1.4. Biochemical characterization of babesipain-1 as a new drug 
target 
Babesipain-1 was expressed as a fusion protein with gluthatione S-transferase 
(GST) and the soluble protein purified by affinity chromatography. The 
recombinant babesipain-1 showed activity against typical peptide substrates of 
cysteine proteases, and was inhibited by E-64, but the low yield of the soluble 
purification prevented additional characterization (Chapter 4). Using the same 
expression construction, we proceeded with the purification and refolding of the 
insoluble form of the recombinant GST-babesipain-1, which constituted the bulk of 
the expressed fusion protein. Conditions for the refolding and activation of the pro-
enzyme to a mature form were successfully optimized to yield sufficient amounts 
of enzyme to proceed with the biochemical characterization of babesipain-1 
(Chapter 5). 
Babesipain-1 showed typical properties of a papain-family cysteine protease, 
including hydrolysis of typical papain-family peptide substrate, an acidic pH 
optimum, requirement for a reducing environment for maximum activity, and 
inhibition by standard cysteine protease inhibitors. 
The optimum pH for the protease activity against peptide substrates was 5.5, but 
enzymatic activity was observed between pH 4.0 and pH 9.0, a wider range than 
the observed for the cysteine proteases falcipain-2 and -3 from P. falciparum, pH 
4.5 to 8.0 and pH 4.0 to 7.5 respectively (Sijwali et al., 2001b). At slightly basic pH 
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7.5, babesipain-1 maintained 83% of maximum activity, falcipain-2 less than 50% 
and falcipain-3 showed no activity (Sijwali et al., 2001b). This suggests a role for 
babesipain-1 in the degradation of host proteins in the cytosol where a slightly 
basic optimum pH would be ideal. Falcipain-2 cleaves cytoskeletal proteins, at a pH 
optimum of 7.5 to 8.0, and facilitates erythrocyte rupture by mature schizonts (Dua 
et al., 2001; Hanspal et al., 2002), and babesipain-1 may play a similar role. 
 
 
6.2. Conclusions 
A new molecular method for the direct detection of B. bovis and B. bigemina was 
developed for the analysis of samples from Mozambique and the new method was 
more sensitive than other two widely used methods. 
Bovine babesiosis in Mozambique is widely distributed and common in the 
province of Maputo, but there are locations with low prevalence of this disease, 
and the desired status of endemic stability cannot be therefore guaranteed. 
Cysteine proteases from Babesia spp. were identified and are promising drug 
targets, due to their reduced numbers in the genomes and essential roles in the life 
cycle. The recombinant and active cysteine protease babesipain-1 was expressed 
and characterized and its availability allows now the screening for specific 
inhibitors. 
 
 
6.3. Future work 
The new seminested hot-start PCR can now be used in epidemiological studies in 
Mozambique to address the relationship between babesiosis and the factors 
affecting it´s transmission: vector, climate, tick control, and bovine breed 
resistance. 
The seminested hot-start PCR should be validated for global use, by testing 
samples from different parts of the world and comparing the results with another 
method results to detect the existence of different strains that may not be detected 
by the current primers. Alternatively, the design of primers against a multi copy 
gene instead of the single copy aspartic protease gene, in combination with the 
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long primers and hot-start polymerase strategy may increase the sensitivity in the 
first PCR, excluding the need of a second PCR and the contamination issues 
associated. 
The importance of the different babesipains in the infection process in the 
vertebrate host and consequently as drug targets can be studied by first evaluating 
the expression profile of these cysteine protease genes in different life cycle stages 
using RT-PCR, and second by gene disruption using RNA interference or 
transgenetics, although both techniques have to be first developed for Babesia 
species. 
A different expression and purification method for babesipain-1 should be 
attempted since the enzyme was obtained in a final mixture of partially processed 
pro-enzyme, GST and mature enzyme, and this crude mixture may interfere in the 
final activity profile. A truncated form of the gene can be expressed in a 
recombinant system without the majority of the pro-part and with a smaller tag 
like poly histidine, which allows the purification of the insoluble form in opposition 
to GST that only allows the purification of the soluble form. 
Recombinant active babesipain-1 can be used in the screening for specific 
inhibitors in a microtiter format for large scale analysis. The selected inhibitors can 
then be evaluated using in vitro cultures. 
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